EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 02007R1451-20130901
Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (Text with EEA relevance)
Consolidated text: Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (Text with EEA relevance)
Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (Text with EEA relevance)
No longer in force
2007R1451 — EN — 01.09.2013 — 002.001
This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
|
COMMISSION REGULATION (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (OJ L 325, 11.12.2007, p.3) |
Amended by:
|
|
|
Official Journal |
||
|
No |
page |
date |
||
|
L 90 |
4 |
10.4.2010 |
||
|
L 173 |
34 |
26.6.2013 |
||
COMMISSION REGULATION (EC) No 1451/2007
of 4 December 2007
on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market
(Text with EEA relevance)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market ( 1 ), and in particular Article 16(2) thereof,
Whereas:|
(1) |
Pursuant to Directive 98/8/EC, Member States may only authorise the placing on the market of biocidal products containing active substances included in Annex I, IA or IB to that Directive. However, under the transitional measures provided for in Article 16(1) of Directive 98/8/EC Member States may allow the placing on the market of biocidal products containing active substances not listed in Annex I, IA or IB to Directive 98/8/EC which were already on the market on 14 May 2000, hereinafter ‘existing active substances’. Pursuant to paragraph 2 of that same Article, a 10-year programme of work is to be carried out for the review of all existing active substances. This programme of work was intended to identify the existing active substances and determine those to be evaluated under the review programme with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC. |
|
(2) |
The initial phase of the programme was laid down in Commission Regulation (EC) No 1896/2000 of 7 September 2000 on the first phase of the programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council on biocidal products ( 2 ). |
|
(3) |
Under Regulation (EC) No 1896/2000, existing active substances for use in biocidal products had to be identified, and those to be evaluated with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC in one or more product types had to be notified no later than 28 March 2002. |
|
(4) |
Commission Regulation (EC) No 2032/2003 of 4 November 2003 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, and amending Regulation (EC) No 1896/2000 ( 3 ) established a list of existing active substances. That list covered active substances that had been identified in accordance with Article 3(1) or Article 5(2) of Regulation (EC) No 1896/2000 or in respect of which equivalent information had been submitted in a notification in accordance with Article 4(1) of that Regulation. |
|
(5) |
Regulation (EC) No 2032/2003 also established, in Annex II, an exhaustive list of existing active substances to be evaluated under the review programme. That list covered active substances in respect of which at least one notification had been accepted in accordance with Article 4(2) of Regulation (EC) No 1896/2000 or in which a Member State had expressed an interest in accordance with Article 5(3) of that Regulation. That list specified the product types concerned. |
|
(6) |
Regulation (EC) No 2032/2003 allowed for a number of active substances or substance/product type combinations that were not originally covered by the review programme, to be examined on the same conditions as the active substances evaluated under the review programme, provided that interested operators submitted complete dossiers before 1 March 2006. |
|
(7) |
Article 4(2) of Regulation (EC) No 2032/2003 set 1 September 2006 as the date from which products containing active substances not examined under the review programme should be withdrawn from the market. |
|
(8) |
Article 4(3) of Regulation (EC) No 2032/2003 provided that the existing active substances that had not been identified by the persons using them in biocidal products were to be deemed not to have been placed on the market for biocidal purposes before 14 May 2000. However, this assimilation to new active substances should not be taken to mean that the unlawfully non-identified existing active substances may benefit from a provisional authorisation or from the longer data protection period reserved to genuinely new active substances. Whereas a clarification in that sense should be added to that provision. |
|
(9) |
Regulation (EC) No 2032/2003 introduced the possibility for Member States to apply for a derogation for biocidal products containing identified existing active substances that are not examined under the review programme, which Member States claim are essential for reasons of health, safety, or protection of cultural heritage or critical for the functioning of society in the absence of technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment or health. Such derogation is granted to the requesting Member States only if the requests are justified, if continued use does not give rise to concerns for human health and the environment, and if, where appropriate, alternatives are being developed. It is appropriate to continue to allow Member States to apply for such a derogation, including in respect of an active substance which it has been decided not to include in Annex I, IA or IB to Directive 98/8/EC. Since the review programme referred to in Article 16(2) of Directive 98/8/EC runs only until 14 May 2010, any such derogation should not continue beyond that date. |
|
(10) |
Certain substances or products that are normally consumed by humans or animals for their subsistence may also be used to attract or to repel harmful organisms. For these substances, there is general agreement that the authorisation/registration requirements of Directive 98/8/EC seem unjustified and that they should be expressly excluded from its scope. Considering that a revision of Directive 98/8/EC will take a significant amount of time during which the viability of those products on the market might be irreversibly affected, it is appropriate to postpone their withdrawal from the market until 14 May 2010. |
|
(11) |
A Member State which has indicated an interest in seeking review of a particular active substance should not be designated Rapporteur Member State for that substance. |
|
(12) |
In order to avoid duplication of work, and in particular to reduce testing involving vertebrate animals, the requirements concerning preparation and submission of the complete dossier should be such as to encourage those whose notifications have been accepted, hereinafter ‘participants’, to act collectively, in particular by submitting collective dossiers. It should be possible for the Rapporteur Member State to make available the reference to any test involving vertebrate animals that has been carried out in respect of a notified existing active substance unless that reference is confidential under Article 19 of Directive 98/8/EC. Also, in order to gain experience on the appropriateness of data requirements and to ensure that the review of active substances is carried out in a cost-effective way, participants should be encouraged to provide information on the costs of compiling a dossier and on the need to carry out tests on vertebrate animals. |
|
(13) |
In order to avoid delays, participants should start discussions as early as possible with Rapporteur Member States in order to resolve uncertainties in relation to data requirements. Applicants, other than participants, who wish to apply in accordance with Article 11 of Directive 98/8/EC for inclusion in Annex I, IA or IB thereto of an active substance/product type combination being evaluated under the review programme should submit complete dossiers for that combination no earlier or no later than participants so as not to disturb the smooth functioning of the review programme or create a disadvantage to the participants. |
|
(14) |
The requirements concerning the content and format of dossiers and the number of dossiers to be submitted should be defined. |
|
(15) |
Provision should be made for cases in which a participant is joined by a producer, formulator or association and in which a participant withdraws from the review programme. |
|
(16) |
Producers, formulators or associations should within certain time limits have the opportunity of taking over the role of participant for an existing active substance/product type combination in respect of which all participants have withdrawn or none of the dossiers meets the requirements. Subject to the same time-limits, it should also be possible in certain circumstances for Member States to indicate an interest and act as a participant for the inclusion in Annex I, IA or IB to Directive 98/8/EC of such a combination. |
|
(17) |
In order to discourage abuse of the opportunity to maintain an active substance on the market while it is examined under the review programme, it should be possible for another person or a Member State to take over the role of participant only once in relation to a given active substance/product type combination. For the same purpose, a person or Member State taking over the role of participant should provide within a certain period evidence of commencing work on a complete dossier. |
|
(18) |
Time limits should be specified within which the Rapporteur Member States must verify the completeness of the dossiers. It should be possible, in exceptional circumstances, for the Rapporteur Member States to establish a new deadline for the submission of parts of a dossier, in particular where the participant has demonstrated that it was impossible to submit information in due time or in order to resolve uncertainties regarding data requirements that remain despite earlier discussions between the participant and the Rapporteur Member State. |
|
(19) |
For each existing active substance, the Rapporteur Member State should examine and evaluate the dossier and present the results to the Commission and the other Member States in the form of a competent authority report and a recommendation as to the decision to be taken with regard to the active substance concerned. In order not to prolong decision-making unnecessarily, the Rapporteur Member State should at the same time consider carefully the need for additional studies. For the same reason, Rapporteur Member States should be obliged to take into consideration information submitted after acceptance of the dossier only under specified conditions. |
|
(20) |
The competent authority reports should be examined by the other Member States before the assessment reports are submitted to the Standing Committee on Biocidal Products. |
|
(21) |
Where, despite a recommendation for inclusion of an active substance in Annex I, IA or IB to Directive 98/8/EC, concerns as referred to in Article 10(5) of that Directive remain, it should be possible for the Commission to take into account, but without prejudice to Article 12 of that Directive, the finalisation of the evaluation on other existing active substances applied for the same use. Provision should be made for Rapporteur Member States to update competent authority reports where necessary. |
|
(22) |
In order to ensure better access to information, assessment reports should be drafted on the basis of the reports submitted by the competent authorities of the Member States and should be covered by the same rules regarding access to information as the reports of the competent authorities. The assessment reports should be derived from the original competent authority report as amended in the light of all the documents, comments and information taken into account during the evaluation process. |
|
(23) |
It should be possible to suspend the procedures provided for in this Regulation in the light of the application of other Community acts, in particular as regards Council Directive 76/769/EEC of 27 July 1976 on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations ( 4 ), and after 1 June 2009, as regards Title VIII and Annex XVII of Regulation (EC) No 1907/2006. |
|
(24) |
In order to ensure the most efficient course of the review programme, a number of active substance/product type combinations have been reassigned to different rapporteur Member States. These developments should be reflected in Annex II of this Regulation. |
|
(25) |
Regulation (EC) No 2032/2003 has been amended on several occasions ( 5 ) in order to take into consideration the accession of new Member States, lessons learned from the implementation to date of the review programme, and in particular in order to provide for the non-inclusion in Annex I, IA or IB to Directive 98/8/EC of a number of active substances, either because the requisite information was not submitted within the prescribed period or in cases where the requirements of Article 10 of the said Directive were not satisfied. This practice of constantly updating Regulation (EC) No 2032/2003 in order to follow the evolution of the review programme has proven ineffectual and time-consuming; furthermore it could create confusion to stakeholders as to which rules apply and which active substances are currently under review. In the interest of clarity, it is preferable to repeal and replace Regulation (EC) No 2032/2003 by a new simplified act which will lay down the rules for the review programme, and that the Commission should adopt separate acts for the future non-inclusion decisions. |
|
(26) |
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products, |
HAS ADOPTED THIS REGULATION:
Article 1
Subject matter
This Regulation lays down detailed rules for the implementation of the programme of work for the systematic examination of all active substances already on the market on 14 May 2000 as active substances of biocidal products, hereinafter ‘the review programme’, referred to in Article 16(2) of Directive 98/8/EC.
Article 2
Definitions
For the purposes of this Regulation the definitions in Article 2 of Directive 98/8/EC and Article 2 of Regulation (EC) No 1896/2000 shall apply.
In addition, ‘participant’ means a person which has submitted a notification that has been accepted by the Commission in accordance with Article 4(2) of Regulation (EC) No 1896/2000 or with Article 3c(1) of this Regulation, or a Member State which has indicated an interest in accordance with Article 5(3) of Regulation (EC) No 1896/2000.
Article 3
Existing active substances
1. The list of active substances identified as available on the market before 14 May 2000 as active substances of biocidal products for purposes other than those referred to in Article 2(2)(c) and (d) of Directive 98/8/EC is set out in Annex I.
2. The exhaustive list of existing active substances to be examined under the review programme is set out in Annex II.
The list includes the following active substances:
(a) existing active substances notified in accordance with Article 4(1) of Regulation (EC) No 1896/2000 or Article 4(2) of Commission Regulation (EC) No 1687/2002 ( 6 );
(b) existing active substances that were not notified, but in respect of which a Member State has indicated an interest in supporting their inclusion in Annex I, IA or IB to Directive 98/8/EC;
(c) existing active substances that were not notified, but for which a dossier was submitted to one of the Member States by 1 March 2006, which was found to comply with the requirements of Annex III to this Regulation and was accepted as complete;
(d) existing active substances notified in accordance with Article 3b.
The list specifies, for each existing active substance included, the product types in respect of which the substance will be examined under the review programme, as well as the Rapporteur Member State designated to carry out the evaluation.
Article 3a
Procedure for the declaration of intention to notify
1. A person or a Member State considering that a biocidal product being placed on the market and containing only existing active substances is covered by Directive 98/8/EC and falls under one or more product-types for which Article 4 prohibits the placing on the market may submit a request to the Commission to allow the notification of the active substances contained in that product for the relevant product-types.
The request shall indicate the relevant active substance/product-type combinations, and a justification for the failure to submit a notification in accordance with Article 4(1) of Regulation (EC) No 1896/2000, or to indicate an interest in accordance with Article 5(3) of that Regulation, or to take over the role of participant in accordance with Article 12 of this Regulation, or to submit a complete dossier in accordance with Article 9(1) of this Regulation.
2. Upon receipt of a request in accordance with paragraph 1, the Commission shall consult Member States on whether the request is acceptable.
The request shall be acceptable if the biocidal product is covered by Directive 98/8/EC and falls under one or more product-types for which Article 4 of this Regulation prohibits the placing on the market and, prior to submitting that request, the applicant held an objectively justified belief, induced by guidance published or written advice given by the Commission or by a competent authority designated in accordance with Article 26 of Directive 98/8/EC, that the product was excluded from the scope of Directive 98/8/EC or that it fell under a different product-type.
However, the request shall not be acceptable if the active substance/product-type combination concerned has already been the subject of a decision not to include it in Annex I or IA to Directive 98/8/EC based on an assessment report reviewed by the Standing Committee on Biocidal Products in accordance with Article 15(4) of this Regulation.
3. Where, following a consultation in accordance with paragraph 2, the Commission finds the request acceptable, it shall accept it and allow the notification of the active substance for the relevant product-types.
However, where the dossier submitted to the Rapporteur Member State for the relevant active substance already contains all the data required for the evaluation of the relevant product-types for which Article 4 prohibits the placing on the market, and the participant which has submitted that dossier wishes to be considered as having notified the active substance for those product-types, the Rapporteur Member State shall inform the Commission thereof, and no additional notification shall be allowed pursuant to the first subparagraph.
The Commission shall inform the Member States thereof and publish that information electronically.
4. A person intending to notify the active substance/product-type combination included in the electronic publication referred to in the third subparagraph of paragraph 3 shall declare that intention to the Commission no later than three months from the date of that electronic publication.
Article 3b
Notification procedure
1. Following the declaration of intention to notify, the person referred to in Article 3a(4) shall submit a notification of the active substance/product-type combination to the European Chemicals Agency established by Regulation (EC) No 1907/2006 (hereinafter referred to as the ‘Agency’) no later than 18 months from the date of the electronic publication referred to in the third subparagraph of Article 3a(3).
The notification shall be made through the Register for Biocidal Products referred to in Article 71 of Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 7 ).
2. The notification shall be submitted in IUCLID format. It shall contain all the information referred to in points 1 to 3 and the table in Annex II to Regulation (EC) No 1896/2000, and proof that the substance was on the market as an active substance of a biocidal product falling under the relevant product-type on the date of the electronic publication referred to in the third subparagraph of Article 3a(3).
3. Unless a Rapporteur Member State has already been designated for the active substance in question, the notifier shall indicate to which competent authority of a Member State it intends to submit a dossier, and provide written confirmation that that competent authority agrees to evaluate the dossier.
4. Upon receipt of a notification, the Agency shall inform the Commission thereof, and inform the notifier of the fees payable under the Regulation adopted pursuant to Article 80(1) of Regulation (EU) No 528/2012. If the notifier fails to pay the fee within 30 days from the receipt of that information, the Agency shall reject the notification and inform the notifier thereof.
5. Upon receipt of payment of the fees, the Agency shall verify within 30 days whether the notification complies with the requirements of paragraph 2. If the notification does not comply with those requirements, the Agency shall grant the notifier a period of 30 days in which to complete or correct the notification. After the expiry of that 30-day period, the Agency shall, within 30 days, either declare that the notification complies with the requirements of paragraph 2 or reject the notification, and inform the notifier thereof.
6. Appeals against decisions of the Agency taken pursuant to paragraph 4 or paragraph 5 shall lie with the Board of Appeal established by Regulation (EC) No 1907/2006. Article 92(1) and (2), and Articles 93 and 94 of Regulation (EC) No 1907/2006 shall apply to such appeal procedures. An appeal shall have suspensive effect.
7. The Agency shall without delay inform the Commission of whether the notification complies with the requirements of paragraph 2 or has been rejected.
Article 3c
Inclusion in, or exclusion from, the review programme
1. Where an active substance is considered notified in accordance with the second subparagraph of Article 3a(3), or where the Agency informs the Commission in accordance with Article 3b(7) that a notification complies with the requirements of Article 3b(2), the Commission shall accept the notification and:
(a) where the active substance/product-type combination concerned is not included in Annex II to this Regulation, include the active substance/product-type combination therein and, where relevant, the active substance in Annex I to this Regulation;
(b) where the active substance/product-type combination concerned is included in Annex II to this Regulation but has been the subject of a Commission decision not to include it in Annex I or IA of Directive 98/8/EC, annul that decision.
2. Where a declaration of intention to notify has not been received within the deadline referred to in Article 3a(4), where a notification has not been received within the deadline referred to in Article 3b(1), or where the Agency informs the Commission in accordance with Article 3b(7) that a notification submitted in accordance with Article 3b(1) has been rejected, the Commission shall inform the Member States thereof and publish that information electronically.
Article 4
Non-inclusion
1. Without prejudice to Articles 5 and 6 of this Regulation and paragraph 2 of this Article, biocidal products containing active substances not listed in Annex II to this Regulation or in Annex I or IA to Directive 98/8/EC shall no longer be placed on the market.
In the case of an active substance listed in Annex II to this Regulation, the first subparagraph shall also apply to that substance in relation to any product type not listed in that Annex.
2. Biocidal products containing active substances listed in Annex II to this Regulation for which a decision was taken not to include these active substances for certain or all of their notified product types in Annex I or IA to Directive 98/8/EC, shall no longer be placed on the market for the product types concerned, with effect from 12 months after the date of such a measure being published, unless otherwise stipulated therein.
3. Without prejudice to Articles 12(1)(b) and 15(2) of Directive 98/8/EC, from the day of entry into force of this Regulation, any active substance not listed in Annex I shall be deemed not to have been placed on the market for biocidal purposes before 14 May 2000.
4. By way of derogation from paragraphs 1 and 2, biocidal products containing an active substance for which the Commission has published electronically the relevant information in accordance with the third subparagraph of Article 3a(3) for the relevant product-types may be placed on the market in accordance with Article 16(1) of Directive 98/8/EC until the date when the Commission has taken a decision to include the active substance/product-type combination in Annex II in accordance with point (a) of Article 3c(1) or to annul a previous non-inclusion decision in accordance with point (b) of Article 3c(1), or for a period of six months from the date when the Commission has published electronically the relevant information in accordance with Article 3c(2).
Article 5
Derogation for essential use
1. Member States may apply to the Commission for a derogation from Article 4(1) where they consider that an active substance is essential for them for reasons of health, safety or protection of cultural heritage or is critical for the functioning of society, and where there are no available technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment and health.
Applications shall be accompanied by a document stating the reasons and justifications.
2. The applications referred to in paragraph 1 shall be forwarded by the Commission to the other Member States and shall be made publicly available by electronic means.
Member States or any person may for a period of 60 days following reception of an application submit comments in writing to the Commission.
3. Taking account of the comments received, the Commission may grant a derogation from Article 4(1) allowing the placing of the substance on the market of the requesting Member States until the date referred to in the first subparagraph of Article 16(2) of Directive 98/8/EC at the latest, provided that the Member States:
(a) ensure that continued use is possible only if products containing the substance are approved for the intended essential use;
(b) conclude that, taking into account all available information, it is reasonable to assume that continued use does not have any unacceptable effect on human or animal health or on the environment;
(c) impose all appropriate risk reduction measures when granting approval;
(d) ensure that such approved biocidal products remaining on the market after 1 September 2006 are relabelled in order to match the use conditions laid down by the Member States in accordance with this paragraph; and
(e) ensure that, where appropriate, alternatives for such uses are being sought by the holders of the approvals or the Member States concerned, or a dossier is being prepared for submission in accordance with the procedure laid down in Article 11 of Directive 98/8/EC at the latest two years before the date referred to in the first subparagraph of Article 16(2) of Directive 98/8/EC.
4. The Member States concerned shall annually inform the Commission on the application of paragraph 3 and in particular on the actions taken pursuant to point (e).
5. Member States may at any time review the approvals of biocidal products for which the period of placing on the market has been extended in accordance with paragraph 3. Whenever there is reason to believe that any of the conditions set in points (a) to (e) of that paragraph are no longer satisfied, the Member States concerned shall without undue delay take steps to remedy the situation or if that is not possible, withdraw the approvals of the biocidal products concerned.
Article 6
Food and Feed
By way of derogation from Article 4(1), Member States may allow until the date referred to in the first subparagraph of Article 16(2) of Directive 98/8/EC at the latest the placing on the market of active substances consisting solely of food or feed that are intended for use as repellents or attractants of product type 19.
For the purposes of this derogation, ‘food or feed’ means any edible substance or product of plant or animal origin, whether processed, partially processed or unprocessed, which is intended or reasonably expected to be ingested by humans or animals; this category does not comprise extracts or individual substances isolated from food or feed.
Article 7
Examination of existing active substances under the review programme
1. The review of an active substance listed in Annex II, in respect of the product types specified, shall be undertaken by the Rapporteur Member State designated for that purpose on the basis of the complete dossier for that substance/product type combination, provided that:
(a) the dossier complies with the requirements set out in Annex III to this Regulation;
(b) the complete dossier is submitted within the period specified in Article 9 of this Regulation for the product type concerned, together with the summary dossier referred to in Article 11(1)(b) of Directive 98/8/EC and defined in Annex III to this Regulation.
An active substance listed in Annex II to this Regulation shall be reviewed exclusively in relation to the product types specified therein.
For the active substance/product type combinations referred to in Article 3(2)(c), with the exception of product types 8 and 14, the evaluation of the dossiers shall commence at the same time as the evaluation of dossiers for active substances contained in the same product types.
2. A Member State which has indicated an interest in supporting the inclusion of an active substance in Annex I, IA or IB to the Directive shall not be designated as Rapporteur Member State in respect of that substance.
3. Without prejudice to Articles 10, 11 and 12 of this Regulation, persons other than participants may apply, in accordance with Article 11 of Directive 98/8/EC, for the inclusion in Annex I, IA or IB thereto of an existing active substance/product type combination that is listed in Annex II to this Regulation. These persons shall submit in that case a complete dossier within the time period specified in Article 9 for that substance/product type combination.
Article 8
Preparation of the complete dossier
1. In the preparation of the complete dossier, all reasonable efforts shall be made, inter alia, to avoid duplication of testing on vertebrate animals and, where appropriate, to establish a collective complete dossier.
2. Before commencing compilation of the complete dossier, a participant shall:
(a) inform the Rapporteur Member State of any testing on vertebrate animals that it has already carried out;
(b) contact the Rapporteur Member State for advice as to the acceptability of justifications for waiving certain studies;
(c) inform the Rapporteur Member State of any intention to carry out further testing on vertebrate animals for the purposes of the complete dossier;
(d) when informed by the Rapporteur Member State that another participant has notified plans to carry out the same tests, make all reasonable efforts to cooperate with that participant in the performance of common testing.
Advice given by Rapporteur Member States in accordance with point (b) of the first subparagraph shall not predetermine the outcome of the completeness check under Article 13(1).
3. A Rapporteur Member State may make available the reference to any test carried out on vertebrate animals in respect of an active substance listed in Annex II to this Regulation, save where that reference is to be treated as confidential in accordance with Article 19 of Directive 98/8/EC. Such reference may include the name of the active substance concerned, the end points of the tests, and the contact address of the data owner.
4. Where a Rapporteur Member State is aware that more than one participant is seeking review of a particular active substance, it shall inform those participants accordingly.
5. Participants seeking review of the same active substance for the same product types shall undertake all reasonable efforts to submit a collective complete dossier, while fully respecting the Community rules on competition.
Where, in those circumstances, a collective dossier is not submitted, each individual dossier shall detail the efforts made to secure cooperation and the reasons for non-participation.
6. Details shall be given in the complete dossier and in the summary dossier of the efforts made to avoid duplication of testing on vertebrate animals.
7. In order to provide information on the costs entailed in applying for review and on the need for animal testing for the purposes of compiling the complete dossier, participants may submit to the Rapporteur Member State together with the complete dossiers a breakdown of the costs of the respective actions and studies carried out.
The Rapporteur Member State shall communicate that information to the Commission when submitting the competent authority report in accordance with Article 14(4).
8. Information on the costs entailed in compiling the complete dossier and on the animal testing carried out for that purpose shall be included in the report referred to in Article 18(5) of Directive 98/8/EC together with any appropriate recommendations concerning modifications of data requirements in order to reduce to a minimum the need for testing on vertebrate animals, and to ensure cost-effectiveness and proportionality.
Article 9
Submission of the complete dossier
1. Unless otherwise indicated by the Rapporteur Member State, a participant shall submit to the Rapporteur Member State one paper and one electronic copy of the complete dossier.
The participant shall also, in accordance with Article 13(3), submit one paper and one electronic copy of the summary dossier to the Commission and to each of the other Member States. However, any Member State wishing to receive copies only in electronic format or additional copies shall inform the Commission, which shall make that information publicly available by electronic means. If the Member State subsequently decides otherwise, it shall inform the Commission without undue delay, whereupon the Commission shall update accordingly the information made publicly available.
2. For the existing active substances listed in Annex II, complete dossiers must be received by the competent authority of the Rapporteur Member State within the following periods:
(a) for product types 8 and 14, until 28 March 2004;
(b) for product types 16, 18, 19 and 21, from 1 November 2005 until 30 April 2006;
(c) for product types 1, 2, 3, 4, 5, 6 and 13, from 1 February 2007 until 31 July 2007;
(d) for product types 7, 9, 10, 11, 12, 15, 17, 20, 22 and 23, from 1 May 2008 until 31 October 2008.
3. By way of derogation from paragraph 2, for active substance/product-type combinations listed in Annex II in accordance with point (a) of Article 3c(1), or for which a decision has been annulled in accordance with point (b) of Article 3c(1), applications for approval of an active substance in accordance with Article 7 of Regulation (EU) No 528/2012 shall be submitted no later than two years from the date of the decision adopted in accordance with points (a) or (b) of Article 3c(1).
Article 10
Joining and replacing of participants
Where, by mutual agreement, a producer, formulator or association joins or replaces a participant for the purposes of submitting the complete dossier, all parties to the agreement shall jointly inform the Commission and the Rapporteur Member State accordingly, attaching any relevant letter of access.
The Commission shall inform accordingly any other participant seeking review of the same active substance in relation to the same product types.
Article 11
Withdrawal of participants
1. Where a participant intends to discontinue participation in the review programme, they shall inform the relevant Rapporteur Member State and the Commission accordingly, in writing and without delay, stating the reasons.
The Commission shall inform accordingly the other Member States and any other participant seeking review of the same active substance in relation to the same product type(s).
2. Where all the participants have withdrawn as regards a particular existing active substance/product type combination, the Commission shall inform the Member States thereof and shall publish that information electronically.
Article 12
Taking over the role of participant
1. Within three months of the electronic publication of the information referred to in Article 11(2), a producer, formulator, association or other person may inform the Commission of their intention to take over the role of participant as regards the existing active substance/product type combination.
Within the time period referred to in the first subparagraph, a Member State may also indicate to the Commission an interest in taking over the role of participant in order to support the inclusion in Annex I, IA or IB to Directive 98/8/EC of the existing active substance/product type combination, where there are uses which the Member State considers essential, in particular for the protection of human health, animal health or the environment.
2. The person or Member State wishing to take over the role of the participant who has withdrawn shall, within three months of informing the Commission of their intention, provide evidence to it that work to compile a complete dossier has been commissioned.
3. On the basis of the evidence referred to in paragraph 2, the Commission shall decide whether or not to allow the interested person or Member State to take over the role of participant.
Where the Commission allows the interested person or Member State to take over the role of participant, it may decide to extend, if necessary, the relevant period for the submission of a complete dossier specified in Article 9.
4. The taking over of the role of participant for a given existing active substance/product type combination may be allowed only once.
5. Where the Commission receives no response pursuant to paragraph 1, it shall take a decision not to include the existing active substance in Annex I, IA or IB to Directive 98/8/EC within the framework of the review programme for the product type(s) concerned.
Article 13
Completeness check of dossiers
1. Within three months of receiving the dossier for an existing active substance/product type combination and no later than three months after the end of the relevant time period specified in Article 9(2) of this Regulation, the Rapporteur Member State shall verify whether the dossier is to be accepted as complete in accordance with Article 11(1)(b) of Directive 98/8/EC.
Where the Rapporteur Member State has initiated consultations with other Member States and the Commission in relation to the acceptability of a dossier, the period may be prolonged until consultations have been finalised, up to a maximum of six months from receipt of the dossier.
2. A Rapporteur Member State may require, as a condition for considering a dossier to be complete, proof of advance payment, in full or in part, of the charges payable under Article 25 of Directive 98/8/EC to be provided in the dossier.
3. Where a dossier is considered to be complete, the Rapporteur Member State shall confirm acceptance of the dossier to the participant and agree to the participant forwarding the summary dossier to the Commission and the other Member States within one month of receiving the confirmation.
If a Member State in receipt of a summary dossier has legitimate reason to believe that the dossier is incomplete, it shall without delay communicate its concerns to the Rapporteur Member State, the Commission and the other Member States.
The Rapporteur Member State shall immediately take up consultations with that Member State and the Commission in order to discuss the concern expressed and resolve divergent opinions.
4. In exceptional circumstances, the Rapporteur Member State may establish a new deadline for the submission of information which, for reasons duly substantiated, the participant was unable to submit in due time.
The participant shall, within three months of being informed of the new deadline, provide evidence to the Rapporteur Member State that work to provide the missing information has been commissioned.
If the Rapporteur Member State considers that it has received sufficient evidence, it shall carry out its evaluation in accordance with Article 14 as if the dossier were complete. Otherwise, the evaluation shall not commence until the missing information is submitted.
5. Where a complete dossier is not received within the period specified in Article 9 or by a new deadline established in accordance with paragraph 4, the Rapporteur Member State shall inform the Commission, giving the reasons put forward by the participant by way of justification.
The Rapporteur Member State shall also inform the Commission in cases where a participant fails to provide the evidence required in accordance with the second subparagraph of paragraph 4. In the cases referred to in the first and second subparagraphs and if no other dossier concerns the same existing active substance/product type combination, all participants shall be deemed to have withdrawn and Articles 11(2) and 12 shall apply mutatis mutandis.
Article 14
Evaluation of dossiers by the Rapporteur Member State
1. Where the Rapporteur Member State considers a dossier to be complete, it shall carry out the evaluation within twelve months of accepting the dossier in accordance with Article 11(2) of Directive 98/8/EC and shall prepare a report on that evaluation, hereinafter ‘the competent authority report’.
Without prejudice to Article 12 of Directive 98/8/EC, the Rapporteur Member State may take into account other relevant technical or scientific information regarding the properties of the active substance, metabolites or residues.
2. At the request of a participant, the Rapporteur Member State may take into account additional information relating to an active substance for which the dossier has been accepted as complete only if the following conditions are fulfilled:
(a) the participant informed the Rapporteur Member State, at the time of submission of the dossier, that preparation of the additional information was under way;
(b) the additional information is submitted no later than nine months after acceptance of the dossier in accordance with Article 13(3);
(c) by comparison with the data originally submitted, the additional information is equally or more reliable owing to the application of the same or higher quality standards;
(d) by comparison with the data originally submitted, the additional information supports a different conclusion concerning the active substance for the purposes of the recommendation under paragraph 6.
The Rapporteur Member State shall take into account additional information submitted by persons other than the participant only if that information satisfies the conditions set out in points (b), (c) and (d) of the first subparagraph.
3. Where relevant in the application of paragraph 1, in particular when additional information has been requested by a deadline established by the Rapporteur Member State, the latter may request that the participant submit updated summary dossiers to the Commission and the other Member States when the additional information is received.
All participants shall be deemed to have withdrawn and Articles 11(2) and 12 shall apply mutatis mutandis if:
(a) the additional information is not received by the deadline;
(b) the participant fails to provide adequate justification for further postponing the deadline;
(c) no other dossier concerns the same existing active substance/product type combination.
4. The Rapporteur Member State shall, without undue delay, send a copy of the competent authority report to the Commission, the other Member States and to the participant.
5. A Rapporteur Member State may decide to withhold the competent authority report if the charges payable under Article 25 of Directive 98/8/EC have not been paid in full, in which case it shall inform the participant and the Commission accordingly.
All participants shall be deemed to have withdrawn and Articles 11(2) and 12 shall apply mutatis mutandis if:
(a) full payment is not received within three months of the date of receipt of that information;
(b) no other dossier concerns the same existing active substance/product type combination.
6. The competent authority report shall be presented in a format to be recommended by the Commission and shall include one of the following:
(a) a recommendation to include the existing active substance in Annex I, IA or IB to Directive 98/8/EC, stating, where appropriate, conditions for inclusion;
(b) a recommendation not to include the existing active substance in Annex I, IA or IB to Directive 98/8/EC, stating the reasons.
Article 15
Commission procedures
1. When the Commission receives a competent authority report pursuant to Article 14(4) of this Regulation it shall, without undue delay, prepare the draft decision referred to in Article 27 of Directive 98/8/EC.
2. Before preparing the draft decision referred to in paragraph 1, the Commission shall, when necessary in the light of the comments received on the competent authority report, consult with experts from the Member States to address any problems remaining unresolved. Where necessary and upon a request from the Commission, the Rapporteur Member State shall prepare an updated competent authority report.
3. Where an existing active substance, despite a recommendation for inclusion pursuant to Article 14(6) of this Regulation, still gives rise to concern, as referred to in Article 10(5) of Directive 98/8/EC, the Commission may, without prejudice to Article 12 of that Directive, take into account the finalisation of the evaluation of other existing active substances applied for the same use.
4. On the basis of the documents and information referred to in Article 27(2) of Directive 98/8/EC, the Rapporteur Member State shall prepare an updated competent authority report, the first part of which shall form the assessment report. The assessment report shall be reviewed within the Standing Committee on Biocidal Products. Where several dossiers have been submitted for the same active substance/product type combination, the Rapporteur Member State shall prepare one assessment report based on the information contained in those dossiers.
Article 16
Access to information
Where a Rapporteur Member State has submitted the competent authority report in accordance with Article 14(4) of this Regulation, or where an assessment report has been finalised or updated in the Standing Committee on Biocidal Products, the Commission shall make the report or any updates thereof publicly available by electronic means, except for information that is to be treated as confidential in accordance with Article 19 of Directive 98/8/EC.
Article 17
Suspension of procedures
Where, in respect of an active substance listed in Annex II to this Regulation, the Commission presents a proposal for amending Directive 76/769/EEC or, with effect from 1 June 2009, Annex XVII of Regulation (EC) No 1907/2006 in order to prohibit its placing on the market or its use, including use for biocidal purposes, in certain or all product types, the procedures provided for in this Regulation concerning that substance for use in the product types concerned may be suspended pending a decision on that proposal.
Article 18
Repeal
Regulation (EC) No 2032/2003 is repealed.
References to the repealed Regulation shall be construed as references to this Regulation.
Article 19
Entry into force
This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
ANNEX I
ACTIVE SUBSTANCES IDENTIFIED AS EXISTING
|
Name (EINECS and/or others) |
EC number |
CAS number |
|
Formaldehyde |
200-001-8 |
50-00-0 |
|
Ergocalciferol/Vitamin D2 |
200-014-9 |
50-14-6 |
|
Lactic acid |
200-018-0 |
50-21-5 |
|
Clofenotane/DDT |
200-024-3 |
50-29-3 |
|
Ascorbic acid |
200-066-2 |
50-81-7 |
|
2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether/Piperonyl butoxide |
200-076-7 |
51-03-6 |
|
2,4-dinitrophenol |
200-087-7 |
51-28-5 |
|
2-imidazol-4-ylethylamine |
200-100-6 |
51-45-6 |
|
Bronopol |
200-143-0 |
52-51-7 |
|
Trichlorfon |
200-149-3 |
52-68-6 |
|
Sodium salicylate |
200-198-0 |
54-21-7 |
|
Fenthion |
200-231-9 |
55-38-9 |
|
Glycerol trinitrate |
200-240-8 |
55-63-0 |
|
Bis(tributyltin) oxide |
200-268-0 |
56-35-9 |
|
Tributyltin acetate |
200-269-6 |
56-36-0 |
|
Coumaphos |
200-285-3 |
56-72-4 |
|
Glycerol |
200-289-5 |
56-81-5 |
|
Chlorhexidine diacetate |
200-302-4 |
56-95-1 |
|
Allyl isothiocyanate |
200-309-2 |
57-06-7 |
|
Cetrimonium bromide/Hexadecyltrimethylammonium bromide |
200-311-3 |
57-09-0 |
|
Urea |
200-315-5 |
57-13-6 |
|
Strychnine |
200-319-7 |
57-24-9 |
|
Propane-1,2-diol |
200-338-0 |
57-55-6 |
|
Ethinylestradiol |
200-342-2 |
57-63-6 |
|
Caffeine |
200-362-1 |
58-08-2 |
|
Diphenoxarsin-10-yl oxide |
200-377-3 |
58-36-6 |
|
Gamma-HCH or Gamma-BHC/Lindane/1,2,3,4,5,6-hexachlorocyclohexane |
200-401-2 |
58-89-9 |
|
Sulfaquinoxaline |
200-423-2 |
59-40-5 |
|
Chlorocresol |
200-431-6 |
59-50-7 |
|
2-phenylethanol |
200-456-2 |
60-12-8 |
|
Dimethoate |
200-480-3 |
60-51-5 |
|
Methylthioninium chloride |
200-515-2 |
61-73-4 |
|
Thiourea |
200-543-5 |
62-56-6 |
|
Dichlorvos |
200-547-7 |
62-73-7 |
|
Carbaryl |
200-555-0 |
63-25-2 |
|
Ethanol |
200-578-6 |
64-17-5 |
|
Formic acid |
200-579-1 |
64-18-6 |
|
Acetic acid |
200-580-7 |
64-19-7 |
|
Benzoic acid |
200-618-2 |
65-85-0 |
|
Propan-2-ol |
200-661-7 |
67-63-0 |
|
Chloroform/Trichloromethane |
200-663-8 |
67-66-3 |
|
Colecalciferol |
200-673-2 |
67-97-0 |
|
Salicylic acid |
200-712-3 |
69-72-7 |
|
Hexachlorophene |
200-733-8 |
70-30-4 |
|
Propan-1-ol |
200-746-9 |
71-23-8 |
|
Butan-1-ol |
200-751-6 |
71-36-3 |
|
Methoxychlor |
200-779-9 |
72-43-5 |
|
Bromomethane/Methyl bromide |
200-813-2 |
74-83-9 |
|
Hydrogen cyanide |
200-821-6 |
74-90-8 |
|
Metaldehyde |
200-836-8 |
9002-91-9 |
|
Carbon disulfide |
200-843-6 |
75-15-0 |
|
Ethylene oxide |
200-849-9 |
75-21-8 |
|
Iodoform/Triiodomethane |
200-874-5 |
75-47-8 |
|
Tert-butyl hydroperoxide |
200-915-7 |
75-91-2 |
|
Trichloronitromethane |
200-930-9 |
76-06-2 |
|
Bornan-2-one/Campher |
200-945-0 |
76-22-2 |
|
(3aS,6aR,7aS,8S,11aS,11bS,11cS)-1,3a,4,5,6a,7,7a,8,11,11a,11b,11c-dodecahydro-2,10-dimethoxy-3,8,11a,11c-tetramethyldibenzo[de,g]chromene-1,5,11-trione/Quassin |
200-985-9 |
76-78-8 |
|
1,3-dibromo-5,5-dimethylhydantoin |
201-030-9 |
77-48-5 |
|
3-beta-hydroxyurs-12-en-28-oic acid/Ursolic acid |
201-034-0 |
77-52-1 |
|
Citric acid |
201-069-1 |
77-92-9 |
|
Citric acid monohydrate |
201-069-1 |
5949-29-1 |
|
1,3,4,5-tetrahydroxycyclohexanecarboxylic acid |
201-072-8 |
77-95-2 |
|
Linalool |
201-134-4 |
78-70-6 |
|
2-methylpropan-1-ol |
201-148-0 |
78-83-1 |
|
2-chloroacetamide |
201-174-2 |
79-07-2 |
|
Bromoacetic acid |
201-175-8 |
79-08-3 |
|
Propionic acid |
201-176-3 |
79-09-4 |
|
Chloroacetic acid |
201-178-4 |
79-11-8 |
|
Glycollic acid |
201-180-5 |
79-14-1 |
|
Peracetic acid |
201-186-8 |
79-21-0 |
|
L-(+)-lactic acid |
201-196-2 |
79-33-4 |
|
p-(1,1-dimethylpropyl)phenol |
201-280-9 |
80-46-6 |
|
Pin-2(3)-ene |
201-291-9 |
80-56-8 |
|
Sennoside A |
201-339-9 |
81-27-6 |
|
Warfarin |
201-377-6 |
81-81-2 |
|
Coumachlor |
201-378-1 |
81-82-3 |
|
Diphacinone |
201-434-5 |
82-66-6 |
|
Ethyl quinine carbonate |
201-500-3 |
83-75-0 |
|
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one/Rotenone |
201-501-9 |
83-79-4 |
|
Anthraquinone |
201-549-0 |
84-65-1 |
|
Dibutyl phthalate |
201-557-4 |
84-74-2 |
|
Salicylanilide |
201-727-8 |
87-17-2 |
|
(+)-tartaric acid |
201-766-0 |
87-69-4 |
|
Pentachlorophenol |
201-778-6 |
87-86-5 |
|
Symclosene |
201-782-8 |
87-90-1 |
|
Chloroxylenol |
201-793-8 |
88-04-0 |
|
2,4,6-trichlorophenol |
201-795-9 |
88-06-2 |
|
Menthol |
201-939-0 |
89-78-1 |
|
Isopulegol |
201-940-6 |
89-79-2 |
|
Thymol |
201-944-8 |
89-83-8 |
|
Guaiacol/2-methoxyphenol |
201-964-7 |
90-05-1 |
|
Biphenyl-2-ol |
201-993-5 |
90-43-7 |
|
Naphthalene |
202-049-5 |
91-20-3 |
|
Propyl 4-hydroxybenzoate |
202-307-7 |
94-13-3 |
|
Butyl 4-hydroxybenzoate |
202-318-7 |
94-26-8 |
|
Dibenzoyl peroxide |
202-327-6 |
94-36-0 |
|
2-ethylhexane-1,3-diol |
202-377-9 |
94-96-2 |
|
Benzotriazole |
202-394-1 |
95-14-7 |
|
3-chloropropane-1,2-diol |
202-492-4 |
96-24-2 |
|
Dichlorophen |
202-567-1 |
97-23-4 |
|
Eugenol |
202-589-1 |
97-53-0 |
|
Allantoin |
202-592-8 |
97-59-6 |
|
Methyl 4-hydroxybenzoate |
202-785-7 |
99-76-3 |
|
Benzyl alcohol |
202-859-9 |
100-51-6 |
|
2,2′-[(1,1,3-trimethylpropane-1,3-diyl)bis(oxy)]bis[4,4,6-trimethyl-1,3,2-dioxaborinane] |
202-899-7 |
100-89-0 |
|
Methenamine/Hexamethylenetetramine |
202-905-8 |
100-97-0 |
|
Triclocarban |
202-924-1 |
101-20-2 |
|
Chlorpropham |
202-925-7 |
101-21-3 |
|
1,1′,1″,1‴!-ethylenedinitrilotetrapropan-2-ol |
203-041-4 |
102-60-3 |
|
2,2′,2″-nitrilotriethanol |
203-049-8 |
102-71-6 |
|
Chlorphenesin |
203-192-6 |
104-29-0 |
|
Anethole |
203-205-5 |
104-46-1 |
|
Cinnamaldehyde/3-phenyl-propen-2-al |
203-213-9 |
104-55-2 |
|
2-ethylhexan-1-ol/Isooctanol |
203-234-3 |
104-76-7 |
|
Citronellol |
203-375-0 |
106-22-9 |
|
Citronellal |
203-376-6 |
106-23-0 |
|
Geraniol |
203-377-1 |
106-24-1 |
|
1,4-dichlorobenzene |
203-400-5 |
106-46-7 |
|
Ethylendiamine |
203-468-6 |
107-15-3 |
|
Chloro-acetaldehyde |
203-472-8 |
107-20-0 |
|
Ethane-1,2-diol |
203-473-3 |
107-21-1 |
|
Glyoxal |
203-474-9 |
107-22-2 |
|
Methyl formate |
203-481-7 |
107-31-3 |
|
Butane-1,3-diol |
203-529-7 |
107-88-0 |
|
Vinyl acetate |
203-545-4 |
108-05-4 |
|
Acetic anhydride |
203-564-8 |
108-24-7 |
|
m-Cresol |
203-577-9 |
108-39-4 |
|
Resorcinol |
203-585-2 |
108-46-3 |
|
Cyanuric acid |
203-618-0 |
108-80-5 |
|
Phenol |
203-632-7 |
108-95-2 |
|
Ethyl formate |
203-721-0 |
109-94-4 |
|
Succinic acid |
203-740-4 |
110-15-6 |
|
Hexa-2,4-dienoic acid/Sorbic acid |
203-768-7 |
110-44-1 |
|
Pyridine |
203-809-9 |
110-86-1 |
|
Morpholine |
203-815-1 |
110-91-8 |
|
Glutaral |
203-856-5 |
111-30-8 |
|
2-Butoxyethanol |
203-905-0 |
111-76-2 |
|
Cetrimonium chloride/Hexadecyl-trimethylammoniumchloride |
203-928-6 |
112-02-7 |
|
Nonanoic acid |
203-931-2 |
112-05-0 |
|
Undecan-2-one/Methyl-nonyl-ketone |
203-937-5 |
112-12-9 |
|
2,2′-(ethylenedioxy)diethanol/Triethylene-glycol |
203-953-2 |
112-27-6 |
|
Undec-10-enoic acid |
203-965-8 |
112-38-9 |
|
Oleic acid |
204-007-1 |
112-80-1 |
|
(Z)-docos-13-enoic acid |
204-011-3 |
112-86-7 |
|
N-(2-ethylhexyl)-8,9,10-trinorborn-5-ene-2,3-dicarboximide |
204-029-1 |
113-48-4 |
|
Propoxur |
204-043-8 |
114-26-1 |
|
Endosulfan |
204-079-4 |
115-29-7 |
|
1,7,7-trimethylbicyclo[2.2.1]hept-2-yl thiocyanatoacetate |
204-081-5 |
115-31-1 |
|
Dicofol |
204-082-0 |
115-32-2 |
|
Linalyl acetate |
204-116-4 |
115-95-7 |
|
3,3′,4′,5,7-pentahydroxyflavone |
204-187-1 |
117-39-5 |
|
1,3-dichloro-5,5-dimethylhydantoin |
204-258-7 |
118-52-5 |
|
Methyl salicylate |
204-317-7 |
119-36-8 |
|
Clorophene |
204-385-8 |
120-32-1 |
|
Ethyl 4-hydroxybenzoate |
204-399-4 |
120-47-8 |
|
Benzyl benzoate |
204-402-9 |
120-51-4 |
|
Piperonal |
204-409-7 |
120-57-0 |
|
Indole |
204-420-7 |
120-72-9 |
|
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl-2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-cyclopropanecarboxylate/Cinerin II |
204-454-2 |
121-20-0 |
|
2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1.alpha.[S*(Z)],3.beta.]]-chrysanthemate/Pyrethrin I |
204-455-8 |
121-21-1 |
|
2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1.alpha.[S*(Z)](3.beta.)-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate/Pyrethrin II |
204-462-6 |
121-29-9 |
|
Benzethonium chloride |
204-479-9 |
121-54-0 |
|
5-nitrothiazol-2-ylamine |
204-490-9 |
121-66-4 |
|
Malathion |
204-497-7 |
121-75-5 |
|
Fenitrothion |
204-524-2 |
122-14-5 |
|
Cetalkonium chloride |
204-526-3 |
122-18-9 |
|
Benzyldimethyl(octadecyl)ammonium chloride |
204-527-9 |
122-19-0 |
|
Simazine |
204-535-2 |
122-34-9 |
|
Propham |
204-542-0 |
122-42-9 |
|
4-Phenylbutanone |
204-555-1 |
122-57-6 |
|
2-Phenoxyethanol |
204-589-7 |
122-99-6 |
|
Cetylpyridinium chloride |
204-593-9 |
123-03-5 |
|
Cetylpyridinium chloride monohydrate |
204-593-9 |
6004-24-6 |
|
2-Ethylhexanal |
204-596-5 |
123-05-7 |
|
Pyridazine-3,6-diol/Maleic hydrazide |
204-619-9 |
123-33-1 |
|
Adipic acid |
204-673-3 |
124-04-9 |
|
Octanoic acid |
204-677-5 |
124-07-2 |
|
Dodecylamine/Laurylamine |
204-690-6 |
124-22-1 |
|
Carbon dioxide |
204-696-9 |
124-38-9 |
|
Sodium dimethylarsinate |
204-708-2 |
124-65-2 |
|
Exo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol |
204-712-4 |
124-76-5 |
|
Nitromethylidynetrimethanol |
204-769-5 |
126-11-4 |
|
Sodium acetate |
204-823-8 |
127-09-3 |
|
Sodium N-chlorobenzenesulphonamide |
204-847-9 |
127-52-6 |
|
Tosylchloramide sodium |
204-854-7 |
127-65-1 |
|
Bis(2,3,3,3-tetrachloropropyl) ether |
204-870-4 |
127-90-2 |
|
Potassium dimethyldithiocarbamate |
204-875-1 |
128-03-0 |
|
Sodium dimethyldithiocarbamate |
204-876-7 |
128-04-1 |
|
N-bromosuccinimide |
204-877-2 |
128-08-5 |
|
N-chlorosuccinimide |
204-878-8 |
128-09-6 |
|
2,6-di-tert-butyl-p-cresol |
204-881-4 |
128-37-0 |
|
Warfarin sodium |
204-929-4 |
129-06-6 |
|
Dimethyl phthalate |
205-011-6 |
131-11-3 |
|
Sodium pentachlorophenolate |
205-025-2 |
131-52-2 |
|
Sodium 2-biphenylate |
205-055-6 |
132-27-4 |
|
Sodium 2-biphenylate tetrahydrate |
205-055-6 |
6152-33-6 |
|
Captan |
205-087-0 |
133-06-2 |
|
N-(trichloromethylthio)phthalimide/Folpet |
205-088-6 |
133-07-3 |
|
2,4-Dichloro-3,5-xylenol |
205-109-9 |
133-53-9 |
|
Methyl anthranilate |
205-132-4 |
134-20-3 |
|
Bis(8-hydroxyquinolinium) sulphate |
205-137-1 |
134-31-6 |
|
N,N-diethyl-m-toluamide |
205-149-7 |
134-62-3 |
|
Dipropyl pyridine-2,5-dicarboxylate |
205-245-9 |
136-45-8 |
|
Zinc bis(2-ethylhexanoate) |
205-251-1 |
136-53-8 |
|
6-methylbenzotriazole |
205-265-8 |
136-85-6 |
|
Thiram |
205-286-2 |
137-26-8 |
|
Ziram |
205-288-3 |
137-30-4 |
|
Sodium propionate |
205-290-4 |
137-40-6 |
|
Potassium methyldithiocarbamate |
205-292-5 |
137-41-7 |
|
Metam-sodium |
205-293-0 |
137-42-8 |
|
Dipentene |
205-341-0 |
138-86-3 |
|
Disodium cyanodithiocarbamate |
205-346-8 |
138-93-2 |
|
Benzododecinium chloride |
205-351-5 |
139-07-1 |
|
Miristalkonium chloride |
205-352-0 |
139-08-2 |
|
Nitrilo triacetic acid |
205-355-7 |
139-13-9 |
|
p-tolyl acetate |
205-413-1 |
140-39-6 |
|
1,3-bis(hydroxymethyl)urea |
205-444-0 |
140-95-4 |
|
Sodium formate |
205-488-0 |
141-53-7 |
|
2,3-dihydroxypropyl laurate |
205-526-6 |
142-18-7 |
|
Nabam |
205-547-0 |
142-59-6 |
|
Hexanoic acid |
205-550-7 |
142-62-1 |
|
Lauric acid |
205-582-1 |
143-07-7 |
|
Potassium oleate |
205-590-5 |
143-18-0 |
|
Sodium hydrogencarbonate |
205-633-8 |
144-55-8 |
|
Oxalic acid |
205-634-3 |
144-62-7 |
|
Quinolin-8-ol |
205-711-1 |
148-24-3 |
|
Thiabendazole |
205-725-8 |
148-79-8 |
|
Benzothiazole-2-thiol |
205-736-8 |
149-30-4 |
|
Monuron |
205-766-1 |
150-68-5 |
|
Rutoside |
205-814-1 |
153-18-4 |
|
Glyoxylic acid |
206-058-5 |
298-12-4 |
|
Fenchlorphos |
206-082-6 |
299-84-3 |
|
Naled |
206-098-3 |
300-76-5 |
|
5-chlorosalicylic acid |
206-283-9 |
321-14-2 |
|
Diuron |
206-354-4 |
330-54-1 |
|
Potassium thiocyanate |
206-370-1 |
333-20-0 |
|
Diazinon |
206-373-8 |
333-41-5 |
|
Decanoic acid |
206-376-4 |
334-48-5 |
|
Cyanamide |
206-992-3 |
420-04-2 |
|
Metronidazole |
207-136-1 |
443-48-1 |
|
Cineole |
207-431-5 |
470-82-6 |
|
7,8-dihydroxycoumarin |
207-632-8 |
486-35-1 |
|
Sodium carbonate |
207-838-8 |
497-19-8 |
|
2-hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one |
207-880-7 |
499-44-5 |
|
Carvacrol |
207-889-6 |
499-75-2 |
|
6.beta.-acetoxy-3beta-(beta.-D-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolide/Scilliroside |
208-077-4 |
507-60-8 |
|
Barium carbonate |
208-167-3 |
513-77-9 |
|
3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione |
208-293-9 |
520-45-6 |
|
Osalmid |
208-385-9 |
526-18-1 |
|
2,6-Dimethoxy-p-benzoquinone |
208-484-7 |
530-55-2 |
|
Acridine-3,6-diamine dihydrochloride |
208-515-4 |
531-73-7 |
|
Sodium benzoate |
208-534-8 |
532-32-1 |
|
Dazomet |
208-576-7 |
533-74-4 |
|
Trisodium hydrogendicarbonate/Sodium sesquicarbonate |
208-580-9 |
533-96-0 |
|
Silver carbonate |
208-590-3 |
534-16-7 |
|
Crimidine |
208-622-6 |
535-89-7 |
|
Calcium diformate |
208-863-7 |
544-17-2 |
|
Myristic acid |
208-875-2 |
544-63-8 |
|
1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-one |
208-912-2 |
546-80-5 |
|
1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione/Hypericum perforatum |
208-941-0 |
548-04-9 |
|
[4-[4,4′-bis(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride |
208-953-6 |
548-62-9 |
|
Zinc dibenzoate |
209-047-3 |
553-72-0 |
|
Methyl isothiocyanate |
209-132-5 |
556-61-6 |
|
4,4′-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride |
209-321-2 |
569-61-9 |
|
[4-[alpha-[4-(dimethylamino)phenyl]benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride/Malachite green chloride |
209-322-8 |
569-64-2 |
|
Potassium benzoate |
209-481-3 |
582-25-2 |
|
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (all isomers; ratio: 1:1:1:1:1:1:1:1)/Allethrin |
209-542-4 |
584-79-2 |
|
Sodium 3-(p-anilinophenylazo)benzenesulphonate/Metanil yellow |
209-608-2 |
587-98-4 |
|
DL-lactic acid |
209-954-4 |
598-82-3 |
|
BHC or HCH/Hexachlorocyclohexane |
210-168-9 |
608-73-1 |
|
DL-malic acid |
210-514-9 |
617-48-1 |
|
N-(hydroxymethyl)acetamide |
210-897-2 |
625-51-4 |
|
Succinaldehyde |
211-333-8 |
638-37-9 |
|
2-fluoroacetamide |
211-363-1 |
640-19-7 |
|
Phthalaldehyde |
211-402-2 |
643-79-8 |
|
2-hydroxyethanesulphonic acid, compound with 4,4′-[hexane-1,6-diylbis(oxy)]bis[benzenecarboxamidine] (2:1) |
211-533-5 |
659-40-5 |
|
Tetrahydro-2,5-dimethoxyfuran |
211-797-1 |
696-59-3 |
|
N-[(dichlorofluoromethyl)thio]phthalimide |
211-952-3 |
719-96-0 |
|
Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide/Tolylfluanid |
211-986-9 |
731-27-1 |
|
Levonorgestrel |
212-349-8 |
797-63-7 |
|
Hydroxyl-2-pyridone |
212-506-0 |
822-89-9 |
|
2,6-dimethyl-1,3-dioxan-4-yl acetate |
212-579-9 |
828-00-2 |
|
Terbutryn |
212-950-5 |
886-50-0 |
|
Proflavine hydrochloride |
213-459-9 |
952-23-8 |
|
N′1-quinoxalin-2-ylsulphanilamide, sodium salt |
213-526-2 |
967-80-6 |
|
Norbormide |
213-589-6 |
991-42-4 |
|
(hydroxymethyl)urea |
213-674-8 |
1000-82-4 |
|
Dichlofluanid |
214-118-7 |
1085-98-9 |
|
Copper thiocyanate |
214-183-1 |
1111-67-7 |
|
Dodecyltrimethylammonium bromide |
214-290-3 |
1119-94-4 |
|
Tetradonium bromide |
214-291-9 |
1119-97-7 |
|
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-Tetramethrin |
214-619-0 |
1166-46-7 |
|
4,5-dichloro-3H-1,2-dithiol-3-one |
214-754-5 |
1192-52-5 |
|
Xylenol |
215-089-3 |
1300-71-6 |
|
Bentonite |
215-108-5 |
1302-78-9 |
|
Diarsenic pentaoxide |
215-116-9 |
1303-28-2 |
|
Diboron trioxide |
215-125-8 |
1303-86-2 |
|
Calcium dihydroxide/calcium hydroxide/caustic lime/hydrated lime/slaked lime |
215-137-3 |
1305-62-0 |
|
Calcium oxide/lime/burnt lime/quicklime |
215-138-9 |
1305-78-8 |
|
Potassium hydroxide |
215-181-3 |
1310-58-3 |
|
Sodium hydroxide |
215-185-5 |
1310-73-2 |
|
Silicic acid, potassium salt/Potassium silicate |
215-199-1 |
1312-76-1 |
|
Zinc oxide |
215-222-5 |
1314-13-2 |
|
Trizinc diphosphide |
215-244-5 |
1314-84-7 |
|
Zinc sulphide |
215-251-3 |
1314-98-3 |
|
Trimanganese tetraoxide |
215-266-5 |
1317-35-7 |
|
Copper oxide |
215-269-1 |
1317-38-0 |
|
Dicopper oxide |
215-270-7 |
1317-39-1 |
|
Cresol |
215-293-2 |
1319-77-3 |
|
Aluminum chloride, basic |
215-477-2 |
1327-41-9 |
|
Disodium tetraborate, anhydrous |
215-540-4 |
1330-43-4 |
|
Disodium tetraborate decahydrate |
215-540-4 |
1303-96-4 |
|
Dicopper chloride trihydroxide |
215-572-9 |
1332-65-6 |
|
Chromium trioxide |
215-607-8 |
1333-82-0 |
|
Sodium hydrogendifluoride |
215-608-3 |
1333-83-1 |
|
Naphthenic acids, copper salts |
215-657-0 |
1338-02-9 |
|
2-Butanone, peroxide |
215-661-2 |
1338-23-4 |
|
Naphthenic acids |
215-662-8 |
1338-24-5 |
|
Ammonium hydrogendifluoride |
215-676-4 |
1341-49-7 |
|
Silicic acid, sodium salt |
215-687-4 |
1344-09-8 |
|
Copper(II) chloride |
215-704-5 |
1344-67-8 |
|
N,N″-bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride |
216-994-6 |
1715-30-6 |
|
Monolinuron |
217-129-5 |
1746-81-2 |
|
2,4-dichlorobenzyl alcohol |
217-210-5 |
1777-82-8 |
|
Ethacridine lactate |
217-408-1 |
1837-57-6 |
|
4,4′-(2-ethyl-2-nitropropane-1,3-diyl)bismorpholine |
217-450-0 |
1854-23-5 |
|
Chlorothalonil |
217-588-1 |
1897-45-6 |
|
Dodecylammonium acetate |
217-956-1 |
2016-56-0 |
|
Fluometuron |
218-500-4 |
2164-17-2 |
|
Allyl propyl disulphide |
218-550-7 |
2179-59-1 |
|
4-(2-nitrobutyl)morpholine |
218-748-3 |
2224-44-4 |
|
N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine |
219-145-8 |
2372-82-9 |
|
Didecyldimethylammonium bromide |
219-234-1 |
2390-68-3 |
|
Tolnaftate |
219-266-6 |
2398-96-1 |
|
Bis[[4-[4-(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium] oxalate, dioxalate |
219-441-7 |
2437-29-8 |
|
Dodine |
219-459-5 |
2439-10-3 |
|
2-bromo-1-(4-hydroxyphenyl)ethan-1-one |
219-655-0 |
2491-38-5 |
|
2,2′-dithiobis[N-methylbenzamide] |
219-768-5 |
2527-58-4 |
|
2,2′-[methylenebis(oxy)]bisethanol |
219-891-4 |
2565-36-8 |
|
Phenthoate |
219-997-0 |
2597-03-7 |
|
1,2-benzisothiazol-3(2H)-one |
220-120-9 |
2634-33-5 |
|
2,2′-[(1-methylpropane-1,3-diyl)bis(oxy)]bis[4-methyl-1,3,2-dioxaborinane] |
220-198-4 |
2665-13-6 |
|
2-methyl-2H-isothiazol-3-one |
220-239-6 |
2682-20-4 |
|
Sulphuryl difluoride |
220-281-5 |
2699-79-8 |
|
2-Amino-3-chloro-1,4-naphthoquinone |
220-529-2 |
2797-51-5 |
|
2-chloro-N-(hydroxymethyl)acetamide |
220-598-9 |
2832-19-1 |
|
Troclosene sodium |
220-767-7 |
2893-78-9 |
|
Sodium dichloroisocyanurate dihydrate |
220-767-7 |
51580-86-0 |
|
Chlorpyrifos |
220-864-4 |
2921-88-2 |
|
Mecetronium ethyl sulphate |
221-106-5 |
3006-10-8 |
|
Dodecylethyldimethylammonium ethyl sulphate |
221-108-6 |
3006-13-1 |
|
Bis(trichloromethyl) sulphone |
221-310-4 |
3064-70-8 |
|
Sodium 2-(2-dodecyloxyethoxy)ethyl sulphate |
221-416-0 |
3088-31-1 |
|
4-isopropyl-m-cresol |
221-761-7 |
3228-02-2 |
|
Copper dinitrate |
221-838-5 |
3251-23-8 |
|
Triclosan |
222-182-2 |
3380-34-5 |
|
Temephos |
222-191-1 |
3383-96-8 |
|
Thuj-4(10)-ene |
222-212-4 |
3387-41-5 |
|
Oct-1-ene-3-ol |
222-226-0 |
3391-86-4 |
|
Sodium 5-chloro-2-[4-chloro-2-[[[(3,4-dichlorophenyl)amino]carbonyl]amino]phenoxy]benzenesulphonate |
222-654-8 |
3567-25-7 |
|
(ethylenedioxy)dimethanol |
222-720-6 |
3586-55-8 |
|
Chlorophacinone |
223-003-0 |
3691-35-8 |
|
Dipyrithione |
223-024-5 |
3696-28-4 |
|
Chlorhexidine dihydrochloride |
223-026-6 |
3697-42-5 |
|
Denatonium benzoate |
223-095-2 |
3734-33-6 |
|
Sodium 2,4,6-trichlorophenolate |
223-246-2 |
3784-03-0 |
|
Pyridine-2-thiol 1-oxide, sodium salt |
223-296-5 |
3811-73-2 |
|
Hexahydro-1,3,5-tris(3-methoxypropyl)-1,3,5-triazine |
223-563-6 |
3960-05-2 |
|
4-oxo-4-[(tributylstannyl)oxy]but-2-enoic acid/Tributyltin maleate |
223-701-5 |
4027-18-3 |
|
Methenamine 3-chloroallylochloride |
223-805-0 |
4080-31-3 |
|
N-ethylheptadecafluorooctanesulphonamide |
223-980-3 |
4151-50-2 |
|
Isobutyl 4-hydroxybenzoate/Isobutyl parabene |
224-208-8 |
4247-02-3 |
|
Tributylstannyl salicylate/Tributyltin salicylate |
224-397-7 |
4342-30-7 |
|
Tributylstannyl benzoate/Tributyltin benzoate |
224-399-8 |
4342-36-3 |
|
Sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethanolate |
224-580-1 |
4418-26-2 |
|
Diethylammonium salicylate |
224-586-4 |
4419-92-5 |
|
Dimethyl dicarbonate |
224-859-8 |
4525-33-1 |
|
Farnesol |
225-004-1 |
4602-84-0 |
|
2,2′,2″-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol |
225-208-0 |
4719-04-4 |
|
Octylphosphonic acid |
225-218-5 |
4724-48-5 |
|
Sodium 4-(methoxycarbonyl)phenolate |
225-714-1 |
5026-62-0 |
|
Sulphamidic acid |
226-218-8 |
5329-14-6 |
|
Citral |
226-394-6 |
5392-40-5 |
|
Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione |
226-408-0 |
5395-50-6 |
|
1-benzyl-3,5,7-triaza-1-azoniatricyclo[3.3.1.13,7]decane chloride |
226-445-2 |
5400-93-1 |
|
Dimethyldioctylammonium chloride |
226-901-0 |
5538-94-3 |
|
N-dodecylpropane-1,3-diamine |
226-902-6 |
5538-95-4 |
|
Chlorpyrifos-methyl |
227-011-5 |
5598-13-0 |
|
N,N′-methylenebismorpholine |
227-062-3 |
5625-90-1 |
|
Coumatetralyl |
227-424-0 |
5836-29-3 |
|
Terbuthylazine |
227-637-9 |
5915-41-3 |
|
(R)-p-mentha-1,8-diene |
227-813-5 |
5989-27-5 |
|
4-methoxybenzene-1,3-diamine sulphate |
228-290-6 |
6219-67-6 |
|
Methylene dithiocyanate |
228-652-3 |
6317-18-6 |
|
1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione |
229-222-8 |
6440-58-0 |
|
Dodicin |
229-930-7 |
6843-97-6 |
|
Malic acid |
230-022-8 |
6915-15-7 |
|
(2-bromo-2-nitrovinyl)benzene |
230-515-8 |
7166-19-0 |
|
Didecyldimethylammonium chloride |
230-525-2 |
7173-51-5 |
|
(Z)-N-9-octadecenylpropane-1,3-diamine |
230-528-9 |
7173-62-8 |
|
Benzyldodecyldimethylammonium bromide |
230-698-4 |
7281-04-1 |
|
Prometryn |
230-711-3 |
7287-19-6 |
|
Silver |
231-131-3 |
7440-22-4 |
|
Boron |
231-151-2 |
7440-42-8 |
|
Copper |
231-159-6 |
7440-50-8 |
|
Zinc |
231-175-3 |
7440-66-6 |
|
Sulphur dioxide |
231-195-2 |
7446-09-5 |
|
Dithallium sulphate |
231-201-3 |
7446-18-6 |
|
Calcium dihexa-2,4-dienoate |
231-321-6 |
7492-55-9 |
|
Quinine monohydrochloride dihydrate |
231-437-7 |
6119-47-7 |
|
Iodine |
231-442-4 |
7553-56-2 |
|
Iodine in the form of iodophor |
Mixture |
39392-86-4 |
|
Iodine complex in solution with non-ionic detergents |
Mixture |
|
|
Polyvinylpyrrolidone iodine |
Polymer |
25655-41-8 |
|
Alkylaryl polyether alcohol-iodine complex |
Polymer |
|
|
Iodine complex with ethylene-propylene block co-Polymer (pluronic) |
Polymer |
|
|
Iodine complex with poly alkylenglycol |
Polymer |
|
|
Iodinated Resin/Polyiodide Anion Resin |
Polymer |
|
|
Trisodium orthophosphate (TSP) |
231-509-8 |
7601-54-9 |
|
Silicon dioxide — amorphous |
231-545-4 |
7631-86-9 |
|
Sodium hydrogensulphite |
231-548-0 |
7631-90-5 |
|
Sodium nitrite |
231-555-9 |
7632-00-0 |
|
Sodium peroxometaborate/Sodium perborate hydrate |
231-556-4 |
7632-04-4 |
|
Hydrogen chloride/Hydrochloric acid |
231-595-7 |
7647-01-0 |
|
Sodium chloride |
231-598-3 |
7647-14-5 |
|
Sodium bromide |
231-599-9 |
7647-15-6 |
|
Orthophosphoric acid |
231-633-2 |
7664-38-2 |
|
Hydrogen fluoride |
231-634-8 |
7664-39-3 |
|
Ammonia, anhydrous |
231-635-3 |
7664-41-7 |
|
Sulphuric acid |
231-639-5 |
7664-93-9 |
|
Potassium iodide |
231-659-4 |
7681-11-0 |
|
Sodium hydrogensulphate |
231-665-7 |
7681-38-1 |
|
Sodium fluoride |
231-667-8 |
7681-49-4 |
|
Sodium hypochlorite |
231-668-3 |
7681-52-9 |
|
Disodium disulphite |
231-673-0 |
7681-57-4 |
|
Tetramethrin |
231-711-6 |
7696-12-0 |
|
Sulphur |
231-722-6 |
7704-34-9 |
|
Iron sulphate |
231-753-5 |
7720-78-7 |
|
Iron vitriol/Ferrous sulphate heptahydrate/Iron sulphate heptahydrate |
231-753-5 |
7782-63-0 |
|
Potassium permanganate |
231-760-3 |
7722-64-7 |
|
Hydrogen peroxide |
231-765-0 |
7722-84-1 |
|
Bromine |
231-778-1 |
7726-95-6 |
|
Dipotassium peroxodisulphate |
231-781-8 |
7727-21-1 |
|
Nitrogen |
231-783-9 |
7727-37-9 |
|
Zinc sulphate heptahydrate |
231-793-3 |
7446-20-0 |
|
7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole |
231-810-4 |
7747-35-5 |
|
Sodium sulphite |
231-821-4 |
7757-83-7 |
|
Sodium chlorite |
231-836-6 |
7758-19-2 |
|
Copper chloride |
231-842-9 |
7758-89-6 |
|
Copper sulphate |
231-847-6 |
7758-98-7 |
|
Copper sulphate pentahydrate |
231-847-6 |
7758-99-8 |
|
Silver nitrate |
231-853-9 |
7761-88-8 |
|
Sodium thiosulphate pentahydrate |
231-867-5 |
10102-17-7 |
|
Sodium chlorate |
231-887-4 |
7775-09-9 |
|
Disodium peroxodisulphate/Sodium persulphate |
231-892-1 |
7775-27-1 |
|
Potassium dichromate |
231-906-6 |
7778-50-9 |
|
Calcium hypochlorite |
231-908-7 |
7778-54-3 |
|
Hexahydro-1,3,5-triethyl-1,3,5-triazine |
231-924-4 |
7779-27-3 |
|
Chlorine |
231-959-5 |
7782-50-5 |
|
Ammonium sulphate |
231-984-1 |
7783-20-2 |
|
Silver chloride |
232-033-3 |
7783-90-6 |
|
Aluminium ammonium bis(sulphate) |
232-055-3 |
7784-25-0 |
|
Manganese sulphate |
232-089-9 |
7785-87-7 |
|
Manganese sulphate tetrahydrate |
232-089-9 |
10101-68-5 |
|
Iodine monochloride |
232-236-7 |
7790-99-0 |
|
Terpineol |
232-268-1 |
8000-41-7 |
|
Soybean oil |
232-274-4 |
8001-22-7 |
|
Linseed oil |
232-278-6 |
8001-26-1 |
|
Corn oil |
232-281-2 |
8001-30-7 |
|
Coconut oil |
232-282-8 |
8001-31-8 |
|
Creosote |
232-287-5 |
8001-58-9 |
|
Castor oil |
232-293-8 |
8001-79-4 |
|
Bone oil/Animal oil |
232-294-3 |
8001-85-2 |
|
Rape oil |
232-299-0 |
8002-13-9 |
|
Pyrethrins and Pyrethroids |
232-319-8 |
8003-34-7 |
|
Terpinol |
— |
8006-39-1 |
|
Turpentine oil |
232-350-7 |
8006-64-2 |
|
Garlic ext. |
232-371-1 |
8008-99-9 |
|
Tar, pine/Pine wood tar |
232-374-8 |
8011-48-1 |
|
Beeswax |
232-383-7 |
8012-89-3 |
|
Paraffin oils |
232-384-2 |
8012-95-1 |
|
Oils, avocado |
232-428-0 |
8024-32-6 |
|
Orange, sweet, ext. |
232-433-8 |
8028-48-6 |
|
White mineral oil (petroleum) |
232-455-8 |
8042-47-5 |
|
Saponins |
232-462-6 |
8047-15-2 |
|
Tall-oil rosin |
232-484-6 |
8052-10-6 |
|
Asphalt/Bitumen |
232-490-9 |
8052-42-4 |
|
Copals |
232-527-9 |
9000-14-0 |
|
Lignin |
232-682-2 |
9005-53-2 |
|
Aluminium sulphate |
233-135-0 |
10043-01-3 |
|
Boric acid |
233-139-2 |
10043-35-3 |
|
Aluminium potassium bis(sulphate)/Alum |
233-141-3 |
10043-67-1 |
|
Chlorine dioxide |
233-162-8 |
10049-04-4 |
|
Potassium sulphite |
233-321-1 |
10117-38-1 |
|
Sodium hydrogen 2,2′methylenebis[4-chlorophenolate] |
233-457-1 |
10187-52-7 |
|
2,2-dibromo-2-cyanoacetamide |
233-539-7 |
10222-01-2 |
|
Disilver(1+) sulphate |
233-653-7 |
10294-26-5 |
|
Sodium metaphosphate |
233-782-9 |
10361-03-2 |
|
Oxine-copper |
233-841-9 |
10380-28-6 |
|
Resmethrin |
233-940-7 |
10453-86-8 |
|
N,N′-ethylenebis[N-acetylacetamide] |
234-123-8 |
10543-57-4 |
|
Sodium dichromate |
234-190-3 |
10588-01-9 |
|
Carbendazim |
234-232-0 |
10605-21-7 |
|
Tridecasodium hypochloritetetrakis(phosphate) |
234-307-8 |
11084-85-8 |
|
Natural boric acid |
234-343-4 |
11113-50-1 |
|
Sodium perborate tetrahydrate |
234-390-0 |
10486-00-7 |
|
Perboric acid, sodium salt |
234-390-0 |
11138-47-9 |
|
Naphthenic acids, zinc salts |
234-409-2 |
12001-85-3 |
|
Disodium octaborate |
234-541-0 |
12008-41-2 |
|
Disodium octaborate tetrahydrate |
234-541-0 |
12280-03-4 |
|
[2H4]ammonium chloride |
234-607-9 |
12015-14-4 |
|
Dialuminium chloride pentahydroxide |
234-933-1 |
12042-91-0 |
|
Trimagnesium diphosphide |
235-023-7 |
12057-74-8 |
|
Sodium toluenesulphonate |
235-088-1 |
12068-03-0 |
|
Copper(II) carbonate-copper(II) hydroxide (1:1) |
235-113-6 |
12069-69-1 |
|
Zineb |
235-180-1 |
12122-67-7 |
|
Ammonium bromide |
235-183-8 |
12124-97-9 |
|
Tetraboron disodium heptaoxide, hydrate |
235-541-3 |
12267-73-1 |
|
Maneb |
235-654-8 |
12427-38-2 |
|
Hexaboron dizinc undecaoxide/Zinc borate |
235-804-2 |
12767-90-7 |
|
N-(hydroxymethyl)formamide |
235-938-1 |
13052-19-2 |
|
2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine |
236-035-5 |
13108-52-6 |
|
Nifurpirinol |
236-503-9 |
13411-16-0 |
|
Pyrithione zinc |
236-671-3 |
13463-41-7 |
|
Titanium dioxide |
236-675-5 |
13463-67-7 |
|
Dodecylguanidine monohydrochloride |
237-030-0 |
13590-97-1 |
|
Barium diboron tetraoxide |
237-222-4 |
13701-59-2 |
|
Potassium 2-biphenylate |
237-243-9 |
13707-65-8 |
|
Ammonium tetrafluoroborate |
237-531-4 |
13826-83-0 |
|
Lithium hypochlorite |
237-558-1 |
13840-33-0 |
|
Orthoboric acid, sodium salt |
237-560-2 |
13840-56-7 |
|
Bromine chloride |
237-601-4 |
13863-41-7 |
|
Zinc bis(diethyldithiocarbamate) |
238-270-9 |
14324-55-1 |
|
(benzyloxy)methanol |
238-588-8 |
14548-60-8 |
|
2,2′-oxybis[4,4,6-trimethyl-1,3,2-dioxaborinane] |
238-749-2 |
14697-50-8 |
|
Phoxim |
238-887-3 |
14816-18-3 |
|
Bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copper |
238-984-0 |
14915-37-8 |
|
Bis(8-hydroxyquinolyl) sulphate, monopotassium salt |
239-133-6 |
15077-57-3 |
|
Dibromopropionamide |
239-153-5 |
15102-42-8 |
|
Sodium perborate monohydrate |
239-172-9 |
10332-33-9 |
|
2,2′-methylenebis(6-bromo-4-chlorophenol) |
239-446-8 |
15435-29-7 |
|
Chlorotoluron |
239-592-2 |
15545-48-9 |
|
Disodium carbonate, compound with hydrogen peroxide (2:3) |
239-707-6 |
15630-89-4 |
|
Sodium p-chloro-m-cresolate |
239-825-8 |
15733-22-9 |
|
Chloralose |
240-016-7 |
15879-93-3 |
|
1-bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione |
240-230-0 |
16079-88-2 |
|
(R)-2-(4-chloro-2-methylphenoxy)propionic acid |
240-539-0 |
16484-77-8 |
|
Dipotassium disulphite |
240-795-3 |
16731-55-8 |
|
Methomyl |
240-815-0 |
16752-77-5 |
|
Disodium hexafluorosilicate |
240-934-8 |
16893-85-9 |
|
Hexafluorosilicic acid |
241-034-8 |
16961-83-4 |
|
Benomyl |
241-775-7 |
17804-35-2 |
|
D-gluconic acid, compound with N,N″-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1) |
242-354-0 |
18472-51-0 |
|
O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate |
242-624-8 |
18854-01-8 |
|
Benzoxonium chloride |
243-008-1 |
19379-90-9 |
|
Methyl hydroxymethoxyacetate |
243-271-2 |
19757-97-2 |
|
p-[(diiodomethyl)sulphonyl]toluene |
243-468-3 |
20018-09-1 |
|
Copper dihydroxide |
243-815-9 |
20427-59-2 |
|
Disilver oxide |
243-957-1 |
20667-12-3 |
|
2-butene-1,4-diyl bis(bromoacetate) |
243-962-9 |
20679-58-7 |
|
Aluminium phosphide |
244-088-0 |
20859-73-8 |
|
(benzothiazol-2-ylthio)methyl thiocyanate |
244-445-0 |
21564-17-0 |
|
Tetrachlorvinphos |
244-865-4 |
22248-79-9 |
|
Bendiocarb |
245-216-8 |
22781-23-3 |
|
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Prallethrin |
245-387-9 |
23031-36-9 |
|
Potassium (E,E)-hexa-2,4-dienoate |
246-376-1 |
24634-61-5 |
|
2-tert-Butyl-4-methoxyphenol |
246-563-8 |
25013-16-5 |
|
Bis(hydroxymethyl)urea |
246-679-9 |
25155-29-7 |
|
.alpha.,.alpha.′,.alpha.″-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol |
246-764-0 |
25254-50-6 |
|
2,2′-(octadec-9-enylimino)bisethanol |
246-807-3 |
25307-17-9 |
|
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Cinerin I |
246-948-0 |
25402-06-6 |
|
3-phenoxybenzyl 2-dimethyl-3-(methylpropenyl)cyclopropanecarboxylate/Phenothrin |
247-404-5 |
26002-80-2 |
|
5-chloro-2-methyl-2H-isothiazol-3-one |
247-500-7 |
26172-55-4 |
|
2-octyl-2H-isothiazol-3-one |
247-761-7 |
26530-20-1 |
|
Dodecylbenzenesulphonic acid |
248-289-4 |
27176-87-0 |
|
Lauric acid, monoester with glycerol |
248-337-4 |
27215-38-9 |
|
Zinc neodecanoate |
248-370-4 |
27253-29-8 |
|
Dodecyl(ethylbenzyl)dimethylammonium chloride |
248-486-5 |
27479-28-3 |
|
Cis-tricos-9-ene |
248-505-7 |
27519-02-4 |
|
Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride |
248-595-8 |
27668-52-6 |
|
N′-tert-butyl-N-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine |
248-872-3 |
28159-98-0 |
|
(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (only 1R trans, 1S isomer)/S-Bioallethrin |
249-013-5 |
28434-00-6 |
|
Bioresmethrin |
249-014-0 |
28434-01-7 |
|
3-[3-(4′-bromo[1,1′-biphenyl]-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2-benzopyrone/Bromadiolone |
249-205-9 |
28772-56-7 |
|
Pirimiphos-methyl |
249-528-5 |
29232-93-7 |
|
Lithium heptadecafluorooctanesulphonate |
249-644-6 |
29457-72-5 |
|
5-bromo-5-nitro-1,3-dioxane |
250-001-7 |
30007-47-7 |
|
Trans-isopropyl-3-[[(ethylamino)methoxyphosphinothioyl]oxy]crotonate |
250-517-2 |
31218-83-4 |
|
(Z,E)-tetradeca-9,12-dienyl acetate |
250-753-6 |
30507-70-1 (1) |
|
Decyldimethyloctylammonium chloride |
251-035-5 |
32426-11-2 |
|
Bromochloro-5,5-dimethylimidazolidine-2,4-dione |
251-171-5 |
32718-18-6 |
|
Amitraz |
251-375-4 |
33089-61-1 |
|
3-(4-isopropylphenyl)-1,1-dimethylurea/Isoproturon |
251-835-4 |
34123-59-6 |
|
2-(hydroxymethylamino)ethanol |
251-974-0 |
34375-28-5 |
|
N-[3-(dodecylamino)propyl]glycine |
251-993-4 |
34395-72-7 |
|
2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyldibenzofuran-1,3(2H,9bH)-dione, monosodium salt |
252-204-6 |
34769-44-3 |
|
Sodium 4-ethoxycarbonylphenoxide |
252-487-6 |
35285-68-8 |
|
Sodium 4-propoxycarbonylphenoxide |
252-488-1 |
35285-69-9 |
|
N-[[(4-chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide |
252-529-3 |
35367-38-5 |
|
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole/Imazalil |
252-615-0 |
35554-44-0 |
|
(±)-1-(.beta.-allyloxy-2,4-dichlorophenylethyl)imidazole/Technical grade imazalil |
Plant protection product |
73790-28-0 |
|
S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate/Azamethiphos |
252-626-0 |
35575-96-3 |
|
2-bromo-2-(bromomethyl)pentanedinitrile |
252-681-0 |
35691-65-7 |
|
Benzyldimethyloleylammonium chloride |
253-363-4 |
37139-99-4 |
|
Calcium magnesium oxide/dolomitic lime |
253-425-0 |
37247-91-9 |
|
Calcium magnesium tetrahydroxide/calcium magnesium hydroxide/hydrated dolomitic lime |
254-454-1 |
39445-23-3 |
|
2-phosphonobutane-1,2,4-tricarboxylic acid |
253-733-5 |
37971-36-1 |
|
4-methoxy-m-phenylenediammonium sulphate |
254-323-9 |
39156-41-7 |
|
N,N″-methylenebis[N′-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea] |
254-372-6 |
39236-46-9 |
|
Dinocap |
254-408-0 |
39300-45-3 |
|
alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate |
254-484-5 |
39515-40-7 |
|
Isopropyl (2E,4E)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate/Methoprene |
254-993-2 |
40596-69-8 |
|
Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride |
255-451-8 |
41591-87-1 |
|
Mixture of cis- and trans-p-menthane-3,8 diol/Citriodiol |
255-953-7 |
42822-86-6 |
|
4,4-dimethyloxazolidine |
257-048-2 |
51200-87-4 |
|
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-cis)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate |
257-144-4 |
51348-90-4 |
|
Cyano (3-phenoxybenzyl)-2-(4-chlorophenyl)-3-methylbutyrate/Fenvalerate |
257-326-3 |
51630-58-1 |
|
ethyl N-acetyl-N-butyl-.beta.-alaninate |
257-835-0 |
52304-36-6 |
|
.alpha.-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cypermethrin |
257-842-9 |
52315-07-8 |
|
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Permethrin |
258-067-9 |
52645-53-1 |
|
.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate/Deltamethrin |
258-256-6 |
52918-63-5 |
|
bis(2-ethylhexanoato-O)-.mu.-oxodizinc |
259-049-3 |
54262-78-1 |
|
1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Empenthrin |
259-154-4 |
54406-48-3 |
|
3-iodo-2-propynyl butylcarbamate |
259-627-5 |
55406-53-6 |
|
Tetrakis(hydroxymethyl)phosphonium sulphate(2:1) |
259-709-0 |
55566-30-8 |
|
3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin/Difenacoum |
259-978-4 |
56073-07-5 |
|
4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin/Brodifacoum |
259-980-5 |
56073-10-0 |
|
[2-(2-butoxyethoxy)ethoxy]methanol |
260-097-2 |
56289-76-0 |
|
2-ethoxyethyl bromoacetate |
260-240-9 |
56521-73-4 |
|
N-octyl-N′-[2-(octylamino)ethyl]ethylenediamine |
260-725-5 |
57413-95-3 |
|
1,2-benzisothiazol-3(2H)-one, sodium salt |
261-184-8 |
58249-25-5 |
|
Azaconazole |
262-102-3 |
60207-31-0 |
|
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole/Propiconazole |
262-104-4 |
60207-90-1 |
|
N,N-bis(2-hydroxyethyl)undec-10-enamide |
262-114-9 |
60239-68-1 |
|
2-chloro-3-(phenylsulphonyl)acrylonitrile |
262-395-8 |
60736-58-5 |
|
Tetradecyldimethylbenzylammonium fluoride |
— |
61134-95-0 |
|
[1,1′-Biphenyl]-2-ol, chlorinated |
262-974-5 |
61788-42-9 |
|
Amines, coco alkyl |
262-977-1 |
61788-46-3 |
|
Quaternary ammonium compounds, (hydrogenated tallow alkyl)trimethyl, chlorides |
263-005-9 |
61788-78-1 |
|
Quaternary ammonium compounds, coco alkyltrimethyl, chlorides |
263-038-9 |
61789-18-2 |
|
Quaternary ammonium compounds, benzylcoco alkylbis(hydroxyethyl), chlorides |
263-078-7 |
61789-68-2 |
|
Quaternary ammonium compounds, benzylcoco alkyldimethyl, chlorides |
263-080-8 |
61789-71-7 |
|
Quaternary ammonium compounds, dicocoalkyl dimethyl, chlorides |
263-087-6 |
61789-77-3 |
|
Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides |
263-090-2 |
61789-80-8 |
|
Quaternary ammonium compounds, trimethylsoya alkyl, chlorides |
263-134-0 |
61790-41-8 |
|
Ethanol, 2,2′-iminobis-, N-coco alkyl derivs. |
263-163-9 |
61791-31-9 |
|
1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-nortall-oil alkyl derivs. |
263-171-2 |
61791-39-7 |
|
Imidazolium compounds, 1-benzyl-4,5-dihydro-1-(hydroxyethyl)-2-norcoco alkyl, chlorides |
263-185-9 |
61791-52-4 |
|
Amines, N-tallow alkyldipropylenetri- |
263-191-1 |
61791-57-9 |
|
Amines, N-coco alkyltrimethylenedi- |
263-195-3 |
61791-63-7 |
|
Amines, N-coco alkyltrimethylenedi-, acetates |
263-196-9 |
61791-64-8 |
|
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides |
264-151-6 |
63449-41-2 |
|
4,5-dichloro-2-octyl-2H-isothiazol-3-one |
264-843-8 |
64359-81-5 |
|
2-chloro-N-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]benzamide |
264-980-3 |
64628-44-0 |
|
Distillates (petroleum), solvent-refined light naphthenic |
265-098-1 |
64741-97-5 |
|
Distillates (petroleum), hydrotreated light |
265-149-8 |
64742-47-8 |
|
N-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-6-hydroxy-1,3-dimethyl-2,4-dioxopyrimidine-5-carboxamide |
265-732-7 |
65400-98-8 |
|
.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate |
265-898-0 |
65731-84-2 |
|
Tar acids, coal, crude |
266-019-3 |
65996-85-2 |
|
Glass powder |
266-046-0 |
65997-17-3 |
|
3,3′-methylenebis[5-methyloxazolidine]/Oxazolidin |
266-235-8 |
66204-44-2 |
|
N-cyclopropyl-1,3,5-triazine-2,4,6-triamine |
266-257-8 |
66215-27-8 |
|
Betaines, C12-C14-alkyl dimethyl |
266-368-1 |
66455-29-6 |
|
.alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(1,2,2,2-tetrabromoethyl)cyclopropanecarboxylate/Tralomethrin |
266-493-1 |
66841-25-6 |
|
2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide |
266-583-0 |
67129-08-2 |
|
Cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine |
266-719-9 |
67564-91-4 |
|
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide |
266-994-5 |
67747-09-5 |
|
Fatty acids, C16-18 and C18-unsatd., Me esters |
267-015-4 |
67762-38-3 |
|
.alpha-cyano-3-phenoxybenzyl 3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethyl cyclopropanecarboxylate/Cyhalothrin |
268-450-2 |
68085-85-8 |
|
Dodecylethyldimethylammonium bromide/Laudacit |
269-249-2 |
68207-00-1 |
|
Shale oils |
269-646-0 |
68308-34-9 |
|
.alpha.-cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cyfluthrin |
269-855-7 |
68359-37-5 |
|
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides |
269-919-4 |
68391-01-5 |
|
Quaternary ammonium compounds, di-C6-12-alkyldimethyl, chlorides |
269-925-7 |
68391-06-0 |
|
Benzenesulfonic acid, C10-13-alkyl derivs., sodium salts |
270-115-0 |
68411-30-3 |
|
Quaternary ammonium compounds, benzyl-C8-16-alkyldimethyl, chlorides |
270-324-7 |
68424-84-0 |
|
Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides |
270-325-2 |
68424-85-1 |
|
Betaines, coco alkyldimethyl |
270-329-4 |
68424-94-2 |
|
Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides |
270-331-5 |
68424-95-3 |
|
Fatty acids, coco, reaction products with diethanolamine |
270-430-3 |
68440-04-0 |
|
1-Propanaminium, 3-amino-N,N,N-trimethyl-, N-C12-18 acyl derivs., Me sulfates |
271-063-1 |
68514-93-2 |
|
Amides, coco, N,N-bis(2-hydroxyethyl) |
271-657-0 |
68603-42-9 |
|
Quaternary ammonium compounds, (oxydi-2,1-ethanediyl)bis[coco alkyldimethyl, dichlorides |
271-761-6 |
68607-28-3 |
|
9-Octadecenoic acid (Z)-, sulfonated, potassium salts |
271-843-1 |
68609-93-8 |
|
Urea, reaction products with formaldehyde |
271-898-1 |
68611-64-3 |
|
Imidazolium compounds, 1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-4,5-dihydro-2-norcoco alkyl, hydroxides, sodium salts |
272-043-5 |
68650-39-5 |
|
bis(tetraamminecopper) carbonatedihydroxide |
272-415-7 |
68833-88-5 |
|
1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1) |
272-574-2 |
68890-66-4 |
|
Amines, N-tallowalkyl trimethylenedi-, diacetates |
272-786-5 |
68911-78-4 |
|
Quassia, ext. |
272-809-9 |
68915-32-2 |
|
Fatty acids, C8-10 |
273-086-2 |
68937-75-7 |
|
Sulfuric acid, mono-C12-18-alkyl esters, sodium salts |
273-257-1 |
68955-19-1 |
|
Quaternary ammonium compounds, C12-18-alkyl[(ethylphenyl)methyl]dimethyl, chlorides |
273-318-2 |
68956-79-6 |
|
Didecylmethyl[3-(trimethoxysilyl)propyl]ammonium chloride |
273-403-4 |
68959-20-6 |
|
Quaternary ammonium compounds, benzyl-C10-16-alkyldimethyl, chlorides |
273-544-1 |
68989-00-4 |
|
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1) |
273-545-7 |
68989-01-5 |
|
Sodium N-(hydroxymethyl)glycinate |
274-357-8 |
70161-44-3 |
|
Amines, C10-16-alkyldimethyl, N-oxides |
274-687-2 |
70592-80-2 |
|
Pentapotassium bis(peroxymonosulphate) bis(sulphate) |
274-778-7 |
70693-62-8 |
|
N,N′-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene)bis(octylammonium) dichloride |
274-861-8 |
70775-75-6 |
|
1,3-didecyl-2-methyl-1H-imidazolium chloride |
274-948-0 |
70862-65-6 |
|
ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate/Fenoxycarb |
276-696-7 |
72490-01-8 |
|
Quaternary ammonium compounds, di-C8-18-alkyldimethyl, chlorides |
277-453-8 |
73398-64-8 |
|
1-[(hydroxymethyl)amino]propan-2-ol |
278-534-0 |
76733-35-2 |
|
1-[1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea/Diazolidinylurea |
278-928-2 |
78491-02-8 |
|
Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-) |
279-013-0 |
78948-87-5 |
|
Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-) hexahydrate |
279-013-0 |
114915-85-4 |
|
Tributyltetradecylphosphonium chloride |
279-808-2 |
81741-28-8 |
|
(2-Butoxyethoxy)methanol |
281-648-3 |
84000-92-0 |
|
Zinc, isodecanoate isononanoate complexes, basic |
282-786-7 |
84418-73-5 |
|
Juniper, Juniperus communis, ext. |
283-268-3 |
84603-69-0 |
|
Laurus nobilis, ext. |
283-272-5 |
84603-73-6 |
|
Rosemary, ext. |
283-291-9 |
84604-14-8 |
|
Eucalyptus globulus, ext. |
283-406-2 |
84625-32-1 |
|
Cinnamomum zeylanicum, ext. |
283-479-0 |
84649-98-9 |
|
Margosa ext. |
283-644-7 |
84696-25-3 |
|
Lavender, Lavandula angustifolia angustifolia, ext. |
283-994-0 |
84776-65-8 |
|
Thyme, Thymus serpyllum, ext. |
284-023-3 |
84776-98-7 |
|
Formaldehyde, reaction products with diethylene glycol |
284-062-6 |
84777-35-5 |
|
Formamide, reaction products with formaldehyde |
284-064-7 |
84777-37-7 |
|
Glycine, N-(3-aminopropyl)-, N′-C10-16-alkyl derivs. |
284-065-2 |
84777-38-8 |
|
Lemon, ext. |
284-515-8 |
84929-31-7 |
|
Thyme, Thymus vulgaris, ext. |
284-535-7 |
84929-51-1 |
|
Clove, ext. |
284-638-7 |
84961-50-2 |
|
Tar acids, polyalkylphenol fraction |
284-893-4 |
84989-05-9 |
|
Melaleuca alternifolia, ext./Australian Tea Tree Oil |
285-377-1 |
85085-48-9 |
|
2,4,8,10-tetra(tert-butyl)-6-hydroxy-12H-dibenzo[d,g][1,3,2]dioxaphosphocin 6-oxide, sodium salt |
286-344-4 |
85209-91-2 |
|
Formaldehyde, reaction products with propylene glycol |
286-695-3 |
85338-22-3 |
|
Stannane, tributyl-, mono(naphthenoyloxy) derivs. |
287-083-9 |
85409-17-2 |
|
Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides |
287-089-1 |
85409-22-9 |
|
Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides |
287-090-7 |
85409-23-0 |
|
[R-(Z)]-3-[(12-hydroxy-1-oxo-9-octadecenyl)amino]propyltrimethylammonium methyl sulphate |
287-462-9 |
85508-38-9 |
|
Benzenesulfonic acid, 4-C10-13-sec-alkyl derives. |
287-494-3 |
85536-14-7 |
|
Guanidine, N,N‴-1,3-propanediylbis-, N-coco alkyl derivs., diacetates |
288-198-7 |
85681-60-3 |
|
Sulfonic acids, C13-17-sec-alkane, sodium salts |
288-330-3 |
85711-69-9 |
|
.alpha.-cyano-4-fluoro-3-phenoxybenzyl [1.alpha.(S*),3.alpha.]-(±)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate |
289-244-9 |
86560-93-2 |
|
Chrysanthemum cinerariaefolium, ext. |
289-699-3 |
89997-63-7 |
|
Cymbopogon nardus, ext. |
289-753-6 |
89998-15-2 |
|
Lavender, Lavandula angustifolia, ext. |
289-995-2 |
90063-37-9 |
|
Litsea cubeba, ext. |
290-018-7 |
90063-59-5 |
|
Mentha arvensis, ext. |
290-058-5 |
90063-97-1 |
|
Pelargonium graveolens, ext. |
290-140-0 |
90082-51-2 |
|
Benzenesulfonic acid, mono-C10-14-alkyl derivs., compds. with Me 1H-benzimidazol-2-ylcarbamate |
290-651-9 |
90194-41-5 |
|
Copper, EDTA-complexes |
290-989-7 |
90294-99-8 |
|
Formaldehyde, reaction products with propanolamine |
291-325-9 |
90387-52-3 |
|
Urea, N,N′-bis(hydroxymethyl)-, reaction products with 2-(2-butoxyethoxy)ethanol, ethylene glycol and formaldehyde |
292-348-7 |
90604-54-9 |
|
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, bromides |
293-522-5 |
91080-29-4 |
|
Fir, Abies sibirica, ext. |
294-351-9 |
91697-89-1 |
|
Juniper, Juniperus mexicana, ext. |
294-461-7 |
91722-61-1 |
|
Lavender, Lavandula hybrida, ext./Lavandin oil |
294-470-6 |
91722-69-9 |
|
Amines, N-(3-aminopropyl)-N′-coco alkyltrimethylenedi-, monoacrylated |
294-702-6 |
91745-32-3 |
|
Cymbopogon winterianus, ext. |
294-954-7 |
91771-61-8 |
|
Lemongrass (Cymbopogon flexuosus) |
295-161-9 |
91844-92-7 |
|
White mineral oil (petroleum), light |
295-550-3 |
92062-35-6 |
|
N-[3-(dodecylamino)propyl]glycine hydrochloride |
298-216-5 |
93778-80-4 |
|
Bis(2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-1,3(2H,9bH)-dibenzofurandionato-O2,O3)copper |
304-146-9 |
94246-73-8 |
|
Citrus, ext. |
304-454-3 |
94266-47-4 |
|
Pine ext. |
304-455-9 |
94266-48-5 |
|
Trimethyl-3-[(1-oxo-10-undecenyl)amino]propylammonium methyl sulphate |
304-990-8 |
94313-91-4 |
|
Peppermint, American, ext. |
308-770-2 |
98306-02-6 |
|
Quaternary ammonium compounds, [2-[[2-[(2-carboxyethyl)(2-hydroxyethyl)amino]ethyl]amino]-2-oxoethyl]coco alkyldimethyl, hydroxides, inner salts |
309-206-8 |
100085-64-1 |
|
Corn cob, powdered |
310-127-6 |
999999-99-4 |
|
Natural lemon juice (filtered) |
310-127-6 |
999999-99-4 |
|
Hedera helix |
310-127-6 |
999999-99-4 |
|
Onion Oil |
310-127-6 |
999999-99-4 |
|
Thuja occidentalis |
310-127-6 |
999999-99-4 |
|
Salvia officinalis |
310-127-6 |
999999-99-4 |
|
Hyssopus officinalis |
310-127-6 |
999999-99-4 |
|
Chrysanthemum vulgare |
310-127-6 |
999999-99-4 |
|
Artemisia absinthium |
310-127-6 |
999999-99-4 |
|
Achillea millefolium |
310-127-6 |
999999-99-4 |
|
Origanum vulgare |
310-127-6 |
999999-99-4 |
|
Majorana hortensis |
310-127-6 |
999999-99-4 |
|
Origanum majorano |
310-127-6 |
999999-99-4 |
|
Rosmarinus officinalis |
310-127-6 |
999999-99-4 |
|
Satureja hortensis |
310-127-6 |
999999-99-4 |
|
Uritica dioica |
310-127-6 |
999999-99-4 |
|
Aesculus hippocastanum |
310-127-6 |
999999-99-4 |
|
Symphytum officinale |
310-127-6 |
999999-99-4 |
|
Equisetum arvense |
310-127-6 |
999999-99-4 |
|
Sambucus nigra |
310-127-6 |
999999-99-4 |
|
1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea/Hexaflumuron |
401-400-1 |
86479-06-3 |
|
1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione |
401-570-7 |
89415-87-2 |
|
1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol/Tebuconazole |
403-640-2 |
107534-96-3 |
|
Reaction products of: glutamic acid and N-(C12-14-alkyl)propylenediamine |
403-950-8 |
164907-72-6 |
|
Mixture of: (C8-18)alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate;(C8-18)alkylbis(2-hydroxyethyl)ammonium 2-ethylhexylhydrogenphosphate |
404-690-8 |
68132-19-4 |
|
(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane |
405-020-7 |
105024-66-6 |
|
2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate/Transfluthrin |
405-060-5 |
118712-89-3 |
|
5,5-dimethyl-perhydro-pyrimidin-2-one .alpha.-(4-trifluoromethylstyryl)-.alpha.-(4-trifluoromethyl)cinnamylidenehydrazone/Hydramethylnon |
405-090-9 |
67485-29-4 |
|
3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether/Etofenprox |
407-980-2 |
80844-07-1 |
|
6-(phthalimido)peroxyhexanoic acid |
410-850-8 |
128275-31-0 |
|
Lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide |
411-690-1 |
111337-53-2 |
|
Methyl neodecanamide |
414-460-9 |
105726-67-8 |
|
Mixture of: alpha-cyano-3-phenoxybenzyl (Z)-(1R,3R)-[(S)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate;alpha-cyano-3-phenoxybenzyl (Z)-(1S,3S)-[(R)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate/Lambda cyhalothrin |
415-130-7 |
91465-08-6 |
|
1-(4-(2-cloro-a,a,a-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea/Flufenoxuron |
417-680-3 |
101463-69-8 |
|
2-butyl-benzo[d]isothiazol-3-one |
420-590-7 |
04299-07-4 |
|
Tetrachlorodecaoxide complex |
420-970-2 |
92047-76-2 |
|
Mixture of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin/Flocoumafen |
421-960-0 |
90035-08-8 |
|
sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/Icaridine |
423-210-8 |
119515-38-7 |
|
N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide |
423-990-1 |
149118-66-1 |
|
Fipronil |
424-610-5 |
120068-37-3 |
|
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride |
426-020-3 |
51229-78-8 |
|
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine/Imidacloprid |
428-040-8 |
138261-41-3 |
|
Thiamethoxam |
428-650-4 |
153719-23-4 |
|
[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate/Imiprothrin |
428-790-6 |
72963-72-5 |
|
5-chloro-2-(4-chlorphenoxy)phenol |
429-209-0 |
3380-30-1 |
|
2-(1-methyl-2-(4-phenoxy-phenoxy)-ethoxy)-pyridine/Pyriproxyfen |
429-800-1 |
95737-68-1 |
|
3-benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine,4-oxide |
431-030-6 |
163269-30-5 |
|
Reaction products of diisopropanolamine with formaldehyde(1:4) |
432-440-8 |
220444-73-5 |
|
Chloromethyl n-octyl disulfide |
432-680-3 |
180128-56-7 |
|
Reaction product of dimethyl adipate, dimethyl glutarate, dimethyl succinate with hydrogen peroxide/Perestane |
432-790-1 |
|
|
Bis(3-aminopropyl)octylamine |
433-340-7 |
86423-37-2 |
|
(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine |
433-460-1 |
210880-92-5 |
|
(E)-2-Octadecenal |
Not yet allocated |
51534-37-3 |
|
(E,Z)-2,13-Octadecadienal |
Not yet allocated |
99577-57-8 |
|
Silver-zinc-aluminium-boronphosphate glass/Glass oxide, silver- and zinc-containing |
Not yet allocated |
398477-47-9 |
|
Silver sodium hydrogen zirconium phosphate |
Not yet allocated |
|
|
Paraformaldehyde |
30525-89-4 |
|
|
Peroxyoctanoic acid |
33734-57-5 |
|
|
Bromomyristyl isoquinoline |
51808-87-8 |
|
|
9-Aminoacridine hydrochloride monohydrate |
52417-22-8 |
|
|
Chlorinated trisodium phosphate |
56802-99-4 |
|
|
Cyclohexylhydroxydiazene 1-oxide, potassium salt |
66603-10-9 |
|
|
(1S,2R,5S)-2-Isopropenyl-5-methylcyclohexanol |
104870-56-6 |
|
|
Silica, amorphous, crystalline-free |
112945-52-5 |
|
|
Denatonium Capsaicinate |
192327-95-0 |
|
|
Tris(N-cyclohexyldiazeniumdioxy)aluminium |
312600-88-7 |
|
|
Bis[1-cyclohexyl-1,2-di(hydroxy-.kappa.O)diazeniumato(2-)]-copper |
312600-89-8 |
|
|
Reaction product of essential oils and ozone in-situ (Open Air Factor (OAF)) |
||
|
Silver zeolite A |
||
|
Silver sodium borosilicate |
||
|
5-Chloro-2-(4-chlorophenoxy)phenol |
||
|
Benzyl-lauryl-dimethyl-myristylammonium chloride/Lauryl-myristyl dimethyl benzyl ammonium chloride |
||
|
((1,2-Ethanediylbis(carbamodithioato))(2-))manganese mixture with ((1,2-ethandiylbis(carbamodithioate))(2-))zinc/Mancozeb |
Plant protection product |
8018-01-7 |
|
Chlorosulfamic acid |
Plant protection product |
17172-27-9 |
|
2-bromo-1-(2,4-dichlorophenyl)vinyl diethyl phosphate/bromfenvinfos |
Plant protection product |
33399-00-7 |
|
Ethyl (2E,4E)-3,7,11-trimethyldodeca-2,4-dienoate/Hydroprene |
Plant protection product |
41096-46-2 |
|
Silicium dioxide/Kieselguhr |
Plant protection product |
61790-53-2 |
|
.alpha.,.alpha.,.alpha.-Trifluoro-N-methyl-4,6-dinitro-N-(2,4,6-tribromophenyl)-o-toluidine/Bromethalin |
Plant protection product |
63333-35-7 |
|
S-Methoprene/Isopropyl (s-(E,E))-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate |
Plant protection product |
65733-16-6 |
|
S-Hydroprene/Ethyl (S-(E,E))-3,7,11-trimethyldodeca-2,4-dienoate |
Plant protection product |
65733-18-8 |
|
Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyrate |
Plant protection product |
66230-04-4 |
|
[1.alpha.(S*),3.alpha.]-(.alpha.)-cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2.2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/alpha-Cypermethrin |
Plant protection product |
67375-30-8 |
|
Abamectin (Mixture of Avermectin B1a; > 80 %, EINECS 265-610-3; and Avermectin B1b; < 20 % EINECS 265-611-9) |
265-610-3 |
71751-41-2 |
|
Cyclopropanecarboxylic acid, 3-[(1Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethyl-, (2-methyl[1,1′-biphenyl]-3-ylmethyl ester, (1R,3R)-rel-/Bifenthrin/Biphenate |
Plant protection product |
82657-04-3 |
|
N-(2-((2,6-Dimethyl)phenyl)amino)-2-oxoethyl)-N,N-diethyl benzenemethanaminiumsaccharide/Denatonium Saccharide |
Plant protection product |
90823-38-4 |
|
.alpha.-(4-Chlorophenyl)-.alpha.-(1-cyclopropylethyl)-1H-1,2,4-triazole-1-ethanol/Cyproconazole |
Plant protection product |
94361-06-5 |
|
3-(3-(4′-Bromo-(1,1′-biphenyl)-4-yl)-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxybenzothiopyran-2-one/3-((RS,3RS;1RS,3SR)-3-(4′-bromobiphenyl-4-yl-1,2,3,4-tetrahydro-1-napthyl)-4-hydroxy-1-benzothin-2-one/Difethialone |
Plant protection product |
104653-34-1 |
|
Guazatine triacetate |
Plant protection product |
115044-19-4 |
|
4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile/Chlorfenapyr |
Plant protection product |
122453-73-0 |
|
Aluminium sodium silicate-silver complex/Silver zeolite |
Plant protection product |
130328-18-6 |
|
Aluminium sodium silicate-silver copper complex/Silver Copper Zeolite |
Plant protection product |
130328-19-7 |
|
Aluminium sodium silicate-silver zinc complex/Silver-Zinc-Zeolite |
Plant protection Product |
130328-20-0 |
|
N-Isononyl-N,N-dimethyl-N-decylammonium chloride |
Plant protection product |
138698-36-9 |
|
N-((6-Chloro-3-pyridinyl)methyl)-N′-cyano-N-methylethanimidamide/Acetamiprid |
Plant protection product |
160430-64-8 |
|
3-phenoxybenzyl (1R)-cis,trans-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-Phenothrin |
Plant protection product |
188023-86-1 |
|
Mixture of 5-Hydroxymethoxymethyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 59720-42-2, 16,0 %) and 5-Hydroxy-1-aza-3,7-dioxabicyclo(3.3.0)octane (EINECS 229-457-6, 28,8 %), and 5-Hydroxypoly[methyleneoxy]methyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 56709-13-8; 5,2 %) in water (50 %) |
Plant protection product |
|
|
[1.alpha.(S*),3.alpha.]-(.alpha.)-Cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dichlorovinyl)-2,2-dimenthylcyclopropanecarboxylate |
Plant protection product |
|
|
S-Cyphenothrin |
Plant protection product |
|
|
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers: 1R trans: 1RS only 1:1)/Bioallethrin/d-trans-Allethrin |
Plant protection product |
|
|
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1)/d-Allethrin |
Plant protection product |
|
|
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3)/Esbiothrin |
Plant protection product |
|
|
Spinosad: fermentation product of soil micro-organism containing Spinosyn A and Spinosyn D |
Plant protection product |
|
|
Butoxy polypropylene glycol |
Polymer |
9003-13-8 |
|
Polydimethylsiloxane |
Polymer |
9016-00-6 |
|
Polymer of N-Methylmethanamine (EINECS 204-697-4 with (chloromethyl)oxirane (EINECS 203-439-8)/Polymeric quaternary ammonium chloride |
Polymer |
25988-97-0 |
|
Polymer of N,N,N,N-tetramethyl-ethane-1,2-diamine and (chloromethyl)oxirane |
Polymer |
25988-98-1 |
|
Homopolymer of 2-tert-butylaminoethyl methacrylate (EINECS 223-228-4) |
Polymer |
26716-20-1 |
|
Polymer of formaldehyde and acrolein |
Polymer |
26781-23-7 |
|
Monohydro chloride of polymer of N,N‴-1,6-hexanediylbis[N′-cyanoguanidine] (EINECS 240-032-4) and hexamethylenediamine (EINECS 204-679-6)/Polyhexamethylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium monohydrochloride) |
Polymer |
27083-27-8/32289-58-0 |
|
Polymer of N,N,N′,N′-tetramethyl-1,6-hexanediamine and 1,6-dichlorohexane |
Polymer |
27789-57-7 |
|
Poly(hexamethylendimethylammonium chloride)/Poly[(dimethylimino)-1,6-hexanediyl-chloride] |
Polymer |
28728-61-2 |
|
N,N,N′,N′–Tetramethylethylenediaminebis(2-chloroethyl)ether copolymer |
Polymer |
31075-24-8 |
|
Poly(hexamethylendiamine guanidinium chloride) |
Polymer |
57028-96-3 |
|
Poly(hexamethylenebiguanide) |
Polymer |
91403-50-8 |
|
Poly(oxy-1,2-ethanediyl), .alpha.-[2-(didecylmethylammonio)ethyl]- .omega.-hydroxy-, propanoate (salt) |
Polymer |
94667-33-1 |
|
N,N-Didecyl(-N-methyl-poly(oxyethyl)ammoniumpropionate/1-Decanaminium, N-decyl-N-(2-hydroxyethyl)-N-methyl-, propanoate (salt) |
Polymer |
107879-22-1 |
|
Copolymer of 2-propenal and propane-1,2-diol |
Polymer |
191546-07-3 |
|
N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate |
Polymer |
214710-34-6 |
|
Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) |
Polymer |
374572-91-5 |
|
Tributyltin coPolymer (TBT-coPolymer) |
Polymer |
|
|
Fat alcohol polyglycol ether |
Polymer |
|
|
Poly(vinyl chloride-co-isobutyl vinyl ether-co-N-vinyl, N′-dimethyl octyl bromide propyl diamine) |
Polymer |
|
|
Polyglycolpolyamine resin |
Polymer |
|
|
Sodium lignosulfonate |
Natural Polymer |
8061-51-6 |
|
Neem/Neem-Vital |
Natural oil |
5945-86-8 |
|
Pinus pumilio oil |
Natural oil |
8000-26-8 |
|
Cedarwood oil |
Natural oil |
8000-27-9 |
|
Lavender oil |
Natural oil |
8000-28-0 |
|
Citronella oil |
Natural oil |
8000-29-1 |
|
Essential oil of eugenia caryophyllus |
Natural oil |
8000-34-8 |
|
Geranium oil |
Natural oil |
8000-46-2 |
|
Eucalyptus Oil |
Natural oil |
8000-48-4 |
|
Orange oil |
Natural oil |
8000-57-9 |
|
Pine oil |
Natural oil |
8002-09-3 |
|
Black pepper oil |
Natural oil |
8006-82-4 |
|
Peppermint oil |
Natural oil |
8006-90-4 |
|
Lemongrass oil |
Natural oil |
8007-02-1 |
|
Penny Royal Oil |
Natural oil |
8007-44-1 |
|
Thyme oil |
Natural oil |
8007-46-3 |
|
Coriander oil |
Natural oil |
8008-52-4 |
|
Spearmint oil |
Natural oil |
8008-75-5 |
|
Valeriana officinalis oil |
Natural oil |
8008-88-6 |
|
Cajuput Oil |
Natural oil |
8008-98-8 |
|
Juniperberry oil |
Natural oil |
8012-91-7 |
|
Cypress Oil |
Natural oil |
8013-86-3 |
|
Patchouli oil |
Natural oil |
8014-09-3 |
|
Cumin Oil |
Natural oil |
8014-13-9 |
|
Palmarosa oil |
Natural oil |
8014-19-5 |
|
Rue oil |
Natural oil |
8014-29-7 |
|
Basilicum Ocimum basilium oil |
Natural oil |
8015-73-4 |
|
Bois de rose oil/Rosewood oil |
Natural oil |
8015-77-8 |
|
Celery oil |
Natural oil |
8015-90-5 |
|
Chamomile oil |
Natural oil |
8015-92-7 |
|
Clove leaf oil (Eugenia caryophyllus) |
Natural oil |
8015-97-2 |
|
Melaleuca oil |
Natural oil |
68647-73-4 |
|
Litsea cubeba oil |
Natural oil |
68855-99-2 |
|
Cornmint oil |
Natural oil |
68917-18-0 |
|
Cedar Oil (Cedarwood oil Texas, Juniperus mexicana oil, 22 %) |
Natural oil |
68990-83-0 |
|
Citrus extract of seeds of tabebuia avellanedae |
Natural oil |
|
|
Essential oil of cymbopogon winterianus |
Natural oil |
|
|
Allium sativum and Allium cepa |
Natural oil |
|
|
Essential oil of cinnamomum zeylanicum |
Natural oil |
|
|
Clove oil (main components: Eugenol (83,8 %), Caryophyllene (12,4 %), Eugenol acetate (0,4 %)) |
Natural oil |
|
|
Fir needle perfume oil: (Ethereal oil, main components: Turpentine oil (30-37,5 %), Terpineol (15-20 %), Isobornyl acetate (15-20 %), Pinene beta (12,5-15 %), Pinene alpha (7-10 %), Coumarin (1-3 %), Terpineol-fraction (1-3%) |
Natural oil |
|
|
Perfume oil Spring Fresh: ethereal oil: main components: Citral-diethylacetal (Citrathal) (1-3 %), Citronellol (1-3 %), Ylanat (1-3 %), Hivertal (1-3 %), Allylcapronate (1-3 %) |
Natural oil |
|
|
Rosas oil |
Natural oil |
|
|
Natural Pyrethrins |
Natural extract |
|
|
Peat extract |
Natural extract |
|
|
Alkyl-benzyl-dimethylammonium chloride/Benzalkonium chloride |
Mixture |
8001-54-5 |
|
Cetrimide |
Mixture |
8044-71-1 |
|
Mixture of 3,6-diamino-10-methylacridinium chloride (EINECS 201-668-8;) and 3,6-acridinediamine/Acriflavine |
Mixture |
8048-52-0 |
|
Mixture of ((3,6-diamino-10-methylacridinium chloride (EINECS 201-668-8) and 3,6-acridinediamine) hydrochloride)/Acriflavine HCl |
Mixture |
8063-24-9 |
|
Benzalkonium saccharinate/Benzalkonium o-sulfobenzimidate |
Mixture |
39387-42-3 |
|
Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6) |
Mixture |
55965-84-9 |
|
Siloxanes and Silicones, di-Me, reaction products with silica/Treated Fumed Silica |
Mixture |
67762-90-7 |
|
Reaction mixture of fatty acids mixed esters (C6-18, derived from coconut oil) with acetic acid and 2,2′-methylenebis(4-chlorophenol) |
Mixture |
106523-52-8 |
|
Amines, n-C10-16-alkyltrimethylenedi-, reaction products with chloroacetic acid |
Mixture |
139734-65-9 |
|
Quaternary ammonium iodides |
Mixture |
308074-50-2 |
|
Reaction products of 5,5-dimethylhydantoin and formaldehyde |
Mixture |
|
|
Reaction products of 2-(2-butoxyethoxy)ethanol and formaldehyde |
Mixture |
|
|
Reaction products of ethylene glycol and formaldehyde |
Mixture |
|
|
Reaction products of urea, ethylene glycol and formaldehyde |
Mixture |
|
|
Reaction products of chloroacetamide, 2(2-butoxyethoxy)ethanol and formaldehyde |
Mixture |
|
|
Mixture of 1-phenoxypropan-2-ol (EINECS 212-222-7) and 2-phenoxypropanol (EINECS 224-027-4) |
Mixture |
|
|
Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium hypochlorite produced in situ |
Mixture |
|
|
Potassium salts of fatty acids (C15-21) |
Mixture |
|
|
Acypetacs copper |
Mixture |
|
|
Acypetacs zinc |
Mixture |
|
|
Webbing clothes moths pheromone: components: E,Z-Octadecadi-2,13-enal (75 %) and E-Octadec-2-enal (25 %) |
Mixture |
|
|
Mixture of chromium trioxide (EINECS 215-607-8; 34,2 %), diarsenic pentoxide (EINECS 215-116-9; 24,1 %), copper(II)oxide (EINECS 215-269-1; 13,7 %), water (EINECS 231-791-2; 28 %) |
Mixture |
|
|
Mixture of chlormethylisothiazolinon, ethandiylbisoxybismethanol, methylisothiazolinon |
Mixture |
|
|
Mixture of bromine (EINECS 231-778-1) and hypobromous acid (CAS-No.: 13517-11-8) manufactured in situ |
Mixture |
|
|
Products of natural fermentation of plants in water, sulphur-containing |
Mixture |
|
|
Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22, saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or hydroxides)/BKC |
Mixture of EINECS listed substances |
|
|
Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/DDAC |
Mixture of EINECS listed substances |
|
|
Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/TMAC |
Mixture of EINECS listed substances |
|
|
Bacillus thuringiensis |
Micro-organism |
68038-71-1 |
|
Bacillus sphaericus |
Micro-organism |
143447-72-7 |
|
Bacillus thuringiensis +D381is subsp. Israelensis |
Micro-organism |
|
|
Bacillus thuringiensis Var. Kurstaky |
Micro-organism |
|
|
Bacillus thuringiensis subsp. Israelensis Serotype H14 |
Micro-organism |
|
|
Bacillus thuringiensis var. israelensis |
Micro-organism |
|
|
Bacillus subtilis |
Micro-organism |
|
|
(1) This substance also has a different CAS number (31654-77-0) according to the ESIS registry. |
||
ANNEX II
ACTIVE SUBSTANCES TO BE EXAMINED UNDER THE REVIEW PROGRAMME
|
Substance |
Rapporteur Member State |
EC number |
CAS number |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
|
Formaldehyde |
DE |
200-001-8 |
50-00-0 |
1 |
2 |
3 |
4 |
5 |
6 |
9 |
11 |
12 |
13 |
20 |
22 |
23 |
||||||||||
|
2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether/Piperonyl butoxide |
EL |
200-076-7 |
51-03-6 |
18 |
19 |
|||||||||||||||||||||
|
Bronopol |
ES |
200-143-0 |
52-51-7 |
1 |
2 |
3 |
4 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
22 |
|||||||||||
|
Diphenoxarsin-10-yl oxide |
FR |
200-377-3 |
58-36-6 |
9 |
||||||||||||||||||||||
|
Chlorocresol |
FR |
200-431-6 |
59-50-7 |
1 |
2 |
3 |
4 |
6 |
9 |
10 |
13 |
|||||||||||||||
|
Dichlorvos |
IT |
200-547-7 |
62-73-7 |
18 |
||||||||||||||||||||||
|
Ethanol |
EL |
200-578-6 |
64-17-5 |
1 |
2 |
3 |
4 |
|||||||||||||||||||
|
Formic acid |
BE |
200-579-1 |
64-18-6 |
1 |
2 |
3 |
4 |
5 |
6 |
9 |
11 |
12 |
13 |
|||||||||||||
|
Benzoic acid |
DE |
200-618-2 |
65-85-0 |
1 |
2 |
3 |
4 |
6 |
11 |
20 |
||||||||||||||||
|
Propan-2-ol |
DE |
200-661-7 |
67-63-0 |
1 |
2 |
3 |
4 |
5 |
6 |
9 |
10 |
11 |
12 |
|||||||||||||
|
Salicylic acid |
LT |
200-712-3 |
69-72-7 |
1 |
2 |
3 |
4 |
6 |
||||||||||||||||||
|
Propan-1-ol |
DE |
200-746-9 |
71-23-8 |
1 |
2 |
3 |
4 |
|||||||||||||||||||
|
Hydrogen cyanide |
CZ |
200-821-6 |
74-90-8 |
8 |
14 |
18 |
||||||||||||||||||||
|
Ethylene oxide |
N |
200-849-9 |
75-21-8 |
2 |
20 |
|||||||||||||||||||||
|
1,3-dibromo-5,5-dimethylhydantoin |
NL |
201-030-9 |
77-48-5 |
2 |
11 |
12 |
||||||||||||||||||||
|
Citric acid |
BE |
201-069-1 |
77-92-9 |
1 |
2 |
3 |
||||||||||||||||||||
|
Linalool |
DK |
201-134-4 |
78-70-6 |
19 |
||||||||||||||||||||||
|
2-chloroacetamide |
EE |
201-174-2 |
79-07-2 |
3 |
6 |
7 |
9 |
10 |
11 |
13 |
||||||||||||||||
|
Bromoacetic acid |
ES |
201-175-8 |
79-08-3 |
4 |
||||||||||||||||||||||
|
Glycollic acid |
LT |
201-180-5 |
79-14-1 |
2 |
3 |
4 |
12 |
|||||||||||||||||||
|
Peracetic acid |
FI |
201-186-8 |
79-21-0 |
1 |
2 |
3 |
4 |
5 |
6 |
11 |
12 |
|||||||||||||||
|
L-(+)-lactic acid |
DE |
201-196-2 |
79-33-4 |
2 |
3 |
4 |
6 |
20 |
||||||||||||||||||
|
Warfarin |
IE |
201-377-6 |
81-81-2 |
14 |
||||||||||||||||||||||
|
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one/Rotenone |
UK |
201-501-9 |
83-79-4 |
17 |
||||||||||||||||||||||
|
Symclosene |
UK |
201-782-8 |
87-90-1 |
2 |
3 |
4 |
5 |
6 |
7 |
9 |
11 |
12 |
||||||||||||||
|
Chloroxylenol |
BE |
201-793-8 |
88-04-0 |
1 |
2 |
3 |
4 |
5 |
6 |
|||||||||||||||||
|
Biphenyl-2-ol |
ES |
201-993-5 |
90-43-7 |
1 |
2 |
3 |
4 |
6 |
7 |
9 |
10 |
13 |
||||||||||||||
|
Naphthalene |
UK |
202-049-5 |
91-20-3 |
19 |
||||||||||||||||||||||
|
Dichlorophen |
IE |
202-567-1 |
97-23-4 |
2 |
3 |
4 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
|||||||||||||
|
Triclocarban |
SK |
202-924-1 |
101-20-2 |
1 |
2 |
4 |
||||||||||||||||||||
|
Cinnamaldehyde/3-phenyl-propen-2-al |
UK |
203-213-9 |
104-55-2 |
2 |
||||||||||||||||||||||
|
Geraniol |
FR |
203-377-1 |
106-24-1 |
18 |
19 |
|||||||||||||||||||||
|
Glyoxal |
FR |
203-474-9 |
107-22-2 |
2 |
3 |
4 |
6 |
12 |
||||||||||||||||||
|
m-Cresol |
FR |
203-577-9 |
108-39-4 |
2 |
3 |
|||||||||||||||||||||
|
Hexa-2,4-dienoic acid/Sorbic acid |
DE |
203-768-7 |
110-44-1 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
|||||||||||||
|
Glutaral |
FI |
203-856-5 |
111-30-8 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
22 |
||||||||||
|
Nonanoic acid |
AT |
203-931-2 |
112-05-0 |
2 |
10 |
19 |
||||||||||||||||||||
|
Undecan-2-one/Methyl-nonyl-ketone |
ES |
203-937-5 |
112-12-9 |
19 |
||||||||||||||||||||||
|
Propoxur |
BE |
204-043-8 |
114-26-1 |
18 |
||||||||||||||||||||||
|
1,3-dichloro-5,5-dimethylhydantoin |
NL |
204-258-7 |
118-52-5 |
2 |
11 |
12 |
||||||||||||||||||||
|
Clorophene |
N |
204-385-8 |
120-32-1 |
1 |
2 |
3 |
4 |
6 |
||||||||||||||||||
|
Benzyl benzoate |
UK |
204-402-9 |
120-51-4 |
2 |
18 |
|||||||||||||||||||||
|
Benzethonium chloride |
BE |
204-479-9 |
121-54-0 |
1 |
||||||||||||||||||||||
|
Fenitrothion |
UK |
204-524-2 |
122-14-5 |
18 |
||||||||||||||||||||||
|
Cetalkonium chloride (1) |
204-526-3 |
122-18-9 |
||||||||||||||||||||||||
|
Benzyldimethyl(octadecyl)ammonium chloride (1) |
204-527-9 |
122-19-0 |
||||||||||||||||||||||||
|
2-Phenoxyethanol |
UK |
204-589-7 |
122-99-6 |
1 |
2 |
3 |
4 |
6 |
7 |
10 |
11 |
13 |
||||||||||||||
|
Cetylpyridinium chloride |
UK |
204-593-9 |
123-03-5 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
9 |
20 |
||||||||||||||
|
Octanoic acid |
AT |
204-677-5 |
124-07-2 |
4 |
18 |
|||||||||||||||||||||
|
Carbon dioxide |
FR |
204-696-9 |
124-38-9 |
14 |
15 |
18 |
19 |
20 |
||||||||||||||||||
|
Sodium dimethylarsinate |
PT |
204-708-2 |
124-65-2 |
18 |
||||||||||||||||||||||
|
Nitromethylidynetrimethanol |
UK |
204-769-5 |
126-11-4 |
2 |
3 |
6 |
11 |
12 |
13 |
|||||||||||||||||
|
Tosylchloramide sodium |
ES |
204-854-7 |
127-65-1 |
1 |
2 |
3 |
4 |
5 |
6 |
9 |
10 |
11 |
||||||||||||||
|
Potassium dimethyldithiocarbamate |
UK |
204-875-1 |
128-03-0 |
2 |
4 |
6 |
9 |
10 |
11 |
12 |
13 |
|||||||||||||||
|
Sodium dimethyldithiocarbamate |
UK |
204-876-7 |
128-04-1 |
2 |
3 |
4 |
5 |
6 |
9 |
10 |
11 |
12 |
13 |
|||||||||||||
|
Warfarin sodium |
IE |
204-929-4 |
129-06-6 |
14 |
||||||||||||||||||||||
|
Sodium 2-biphenylate |
ES |
205-055-6 |
132-27-4 |
1 |
2 |
3 |
4 |
6 |
7 |
9 |
10 |
13 |
||||||||||||||
|
Captan |
IT |
205-087-0 |
133-06-2 |
6 |
7 |
9 |
10 |
|||||||||||||||||||
|
N-(trichloromethylthio)phthalimide/Folpet |
IT |
205-088-6 |
133-07-3 |
6 |
7 |
9 |
10 |
|||||||||||||||||||
|
Methyl anthranilate |
FR |
205-132-4 |
134-20-3 |
19 |
||||||||||||||||||||||
|
N,N-diethyl-m-toluamide |
SE |
205-149-7 |
134-62-3 |
19 |
22 |
|||||||||||||||||||||
|
Thiram |
BE |
205-286-2 |
137-26-8 |
2 |
6 |
7 |
9 |
10 |
11 |
12 |
||||||||||||||||
|
Ziram |
BE |
205-288-3 |
137-30-4 |
2 |
6 |
7 |
9 |
10 |
11 |
12 |
||||||||||||||||
|
Potassium methyldithiocarbamate |
CZ |
205-292-5 |
137-41-7 |
2 |
9 |
11 |
12 |
|||||||||||||||||||
|
Metam-sodium |
BE |
205-293-0 |
137-42-8 |
2 |
4 |
6 |
9 |
11 |
12 |
13 |
20 |
|||||||||||||||
|
Disodium cyanodithiocarbamate |
CZ |
205-346-8 |
138-93-2 |
2 |
9 |
11 |
12 |
|||||||||||||||||||
|
Benzododecinium chloride (1) |
205-351-5 |
139-07-1 |
||||||||||||||||||||||||
|
Miristalkonium chloride (1) |
205-352-0 |
139-08-2 |
||||||||||||||||||||||||
|
1,3-bis(hydroxymethyl)urea |
HU |
205-444-0 |
140-95-4 |
2 |
6 |
9 |
11 |
12 |
13 |
|||||||||||||||||
|
Nabam |
PL |
205-547-0 |
142-59-6 |
2 |
4 |
6 |
9 |
10 |
11 |
12 |
13 |
|||||||||||||||
|
Lauric acid |
DE |
205-582-1 |
143-07-7 |
19 |
||||||||||||||||||||||
|
Thiabendazole |
ES |
205-725-8 |
148-79-8 |
2 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
20 |
|||||||||||||
|
Benzothiazole-2-thiol |
N |
205-736-8 |
149-30-4 |
2 |
7 |
9 |
11 |
12 |
13 |
|||||||||||||||||
|
Naled |
FR |
206-098-3 |
300-76-5 |
18 |
||||||||||||||||||||||
|
Diuron |
DK |
206-354-4 |
330-54-1 |
6 |
7 |
10 |
||||||||||||||||||||
|
Diazinon |
PT |
206-373-8 |
333-41-5 |
18 |
||||||||||||||||||||||
|
Decanoic acid |
AT |
206-376-4 |
334-48-5 |
4 |
18 |
19 |
||||||||||||||||||||
|
Cyanamide |
DE |
206-992-3 |
420-04-2 |
3 |
18 |
|||||||||||||||||||||
|
2-hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one |
SK |
207-880-7 |
499-44-5 |
10 |
||||||||||||||||||||||
|
Sodium benzoate |
DE |
208-534-8 |
532-32-1 |
1 |
2 |
6 |
11 |
20 |
||||||||||||||||||
|
Dazomet |
BE |
208-576-7 |
533-74-4 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
||||||||||||||||
|
Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide/Tolylfluanid |
FI |
211-986-9 |
731-27-1 |
7 |
8 |
10 |
21 |
|||||||||||||||||||
|
Hydroxyl-2-pyridone |
FR |
212-506-0 |
822-89-9 |
2 |
6 |
9 |
10 |
11 |
12 |
13 |
||||||||||||||||
|
2,6-dimethyl-1,3-dioxan-4-yl acetate |
AT |
212-579-9 |
828-00-2 |
2 |
6 |
11 |
12 |
13 |
||||||||||||||||||
|
Terbutryn |
SK |
212-950-5 |
886-50-0 |
7 |
9 |
10 |
||||||||||||||||||||
|
Dichlofluanid |
UK |
214-118-7 |
1085-98-9 |
7 |
8 |
10 |
21 |
|||||||||||||||||||
|
Copper thiocyanate |
FR |
214-183-1 |
1111-67-7 |
21 |
||||||||||||||||||||||
|
Tetradonium bromide |
N |
214-291-9 |
1119-97-7 |
1 |
||||||||||||||||||||||
|
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-Tetramethrin |
DE |
214-619-0 |
1166-46-7 |
18 |
||||||||||||||||||||||
|
4,5-dichloro-3H-1,2-dithiol-3-one |
PL |
214-754-5 |
1192-52-5 |
2 |
6 |
9 |
11 |
12 |
||||||||||||||||||
|
Diboron trioxide |
NL |
215-125-8 |
1303-86-2 |
8 |
||||||||||||||||||||||
|
Calcium dihydroxide/calcium hydroxide/caustic lime/hydrated lime/slaked lime |
UK |
215-137-3 |
1305-62-0 |
2 |
3 |
|||||||||||||||||||||
|
Calcium oxide/lime/burnt lime/quicklime |
UK |
215-138-9 |
1305-78-8 |
2 |
3 |
|||||||||||||||||||||
|
Zinc sulphide |
UK |
215-251-3 |
1314-98-3 |
7 |
9 |
10 |
||||||||||||||||||||
|
Copper oxide |
FR |
215-269-1 |
1317-38-0 |
8 |
||||||||||||||||||||||
|
Dicopper oxide |
FR |
215-270-7 |
1317-39-1 |
21 |
||||||||||||||||||||||
|
Disodium tetraborate, anhydrous |
NL |
215-540-4 |
1330-43-4 |
1 |
2 |
7 |
8 |
9 |
10 |
11 |
13 |
|||||||||||||||
|
2-Butanone, peroxide |
HU |
215-661-2 |
1338-23-4 |
1 |
2 |
3 |
6 |
9 |
22 |
|||||||||||||||||
|
Monolinuron |
UK |
217-129-5 |
1746-81-2 |
2 |
||||||||||||||||||||||
|
2,4-dichlorobenzyl alcohol |
CZ |
217-210-5 |
1777-82-8 |
2 |
6 |
7 |
9 |
10 |
12 |
13 |
||||||||||||||||
|
Chlorothalonil |
NL |
217-588-1 |
1897-45-6 |
6 |
7 |
9 |
10 |
|||||||||||||||||||
|
Fluometuron |
EL |
218-500-4 |
2164-17-2 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
||||||||||||||||
|
4-(2-nitrobutyl)morpholine |
UK |
218-748-3 |
2224-44-4 |
6 |
13 |
|||||||||||||||||||||
|
N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine |
PT |
219-145-8 |
2372-82-9 |
1 |
2 |
3 |
4 |
6 |
8 |
9 |
10 |
11 |
12 |
13 |
||||||||||||
|
Didecyldimethylammonium bromide (2) |
219-234-1 |
2390-68-3 |
||||||||||||||||||||||||
|
Tolnaftate |
PL |
219-266-6 |
2398-96-1 |
9 |
||||||||||||||||||||||
|
2,2′-dithiobis[N-methylbenzamide] |
PL |
219-768-5 |
2527-58-4 |
6 |
7 |
9 |
12 |
13 |
||||||||||||||||||
|
1,2-benzisothiazol-3(2H)-one |
ES |
220-120-9 |
2634-33-5 |
2 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
22 |
||||||||||||||
|
2-methyl-2H-isothiazol-3-one |
SI |
220-239-6 |
2682-20-4 |
2 |
4 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
22 |
|||||||||||||
|
Sulphuryl difluoride |
SE |
220-281-5 |
2699-79-8 |
8 |
18 |
|||||||||||||||||||||
|
Troclosene sodium |
UK |
220-767-7 |
2893-78-9 |
1 |
2 |
3 |
4 |
5 |
6 |
9 |
11 |
12 |
||||||||||||||
|
Sodium dichloroisocyanurate dihydrate |
UK |
220-767-7 |
51580-86-0 |
1 |
2 |
3 |
4 |
5 |
6 |
9 |
11 |
12 |
||||||||||||||
|
Mecetronium ethyl sulphate |
PL |
221-106-5 |
3006-10-8 |
1 |
2 |
|||||||||||||||||||||
|
Bis(trichloromethyl) sulphone |
LT |
221-310-4 |
3064-70-8 |
6 |
9 |
10 |
11 |
12 |
22 |
|||||||||||||||||
|
Triclosan |
DK |
222-182-2 |
3380-34-5 |
1 |
2 |
3 |
7 |
9 |
||||||||||||||||||
|
Oct-1-ene-3-ol |
N |
222-226-0 |
3391-86-4 |
19 |
||||||||||||||||||||||
|
(ethylenedioxy)dimethanol |
PL |
222-720-6 |
3586-55-8 |
2 |
3 |
4 |
6 |
9 |
11 |
12 |
13 |
|||||||||||||||
|
Chlorophacinone |
ES |
223-003-0 |
3691-35-8 |
14 |
||||||||||||||||||||||
|
Dipyrithione |
SE |
223-024-5 |
3696-28-4 |
9 |
||||||||||||||||||||||
|
Sodium 2,4,6-trichlorophenolate |
IE |
223-246-2 |
3784-03-0 |
2 |
3 |
6 |
9 |
|||||||||||||||||||
|
Pyridine-2-thiol 1-oxide, sodium salt |
SE |
223-296-5 |
3811-73-2 |
2 |
3 |
4 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
|||||||||||||
|
Methenamine 3-chloroallylochloride |
PL |
223-805-0 |
4080-31-3 |
6 |
9 |
12 |
13 |
|||||||||||||||||||
|
2,2′,2″-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol |
PL |
225-208-0 |
4719-04-4 |
2 |
3 |
4 |
6 |
9 |
11 |
12 |
13 |
|||||||||||||||
|
Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione |
ES |
226-408-0 |
5395-50-6 |
2 |
3 |
4 |
6 |
9 |
10 |
11 |
12 |
13 |
||||||||||||||
|
Dimethyldioctylammonium chloride (2) |
226-901-0 |
5538-94-3 |
||||||||||||||||||||||||
|
N,N′-methylenebismorpholine |
AT |
227-062-3 |
5625-90-1 |
6 |
9 |
11 |
13 |
|||||||||||||||||||
|
Coumatetralyl |
DK |
227-424-0 |
5836-29-3 |
14 |
||||||||||||||||||||||
|
Terbuthylazine |
UK |
227-637-9 |
5915-41-3 |
2 |
11 |
12 |
||||||||||||||||||||
|
(R)-p-mentha-1,8-diene |
PT |
227-813-5 |
5989-27-5 |
12 |
||||||||||||||||||||||
|
Methylene dithiocyanate |
FR |
228-652-3 |
6317-18-6 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
22 |
|||||||||||||||
|
1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione |
PL |
229-222-8 |
6440-58-0 |
2 |
6 |
11 |
12 |
13 |
||||||||||||||||||
|
(2-bromo-2-nitrovinyl)benzene |
SK |
230-515-8 |
7166-19-0 |
6 |
11 |
12 |
13 |
|||||||||||||||||||
|
Didecyldimethylammonium chloride |
IT |
230-525-2 |
7173-51-5 |
1 |
2 |
3 |
4 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
|||||||||||
|
Benzyldodecyldimethylammonium bromide (1) |
230-698-4 |
7281-04-1 |
||||||||||||||||||||||||
|
Prometryn |
PT |
230-711-3 |
7287-19-6 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
||||||||||||||||
|
Silver |
SE |
231-131-3 |
7440-22-4 |
2 |
4 |
5 |
9 |
11 |
||||||||||||||||||
|
Copper |
FR |
231-159-6 |
7440-50-8 |
2 |
4 |
5 |
11 |
21 |
||||||||||||||||||
|
Sulphur dioxide |
DE |
231-195-2 |
7446-09-5 |
1 |
2 |
4 |
5 |
6 |
9 |
11 |
12 |
13 |
20 |
22 |
||||||||||||
|
Calcium dihexa-2,4-dienoate |
DE |
231-321-6 |
7492-55-9 |
1 |
3 |
6 |
7 |
9 |
20 |
|||||||||||||||||
|
Iodine |
SE |
231-442-4 |
7553-56-2 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
9 |
10 |
11 |
22 |
||||||||||||
|
Silicon dioxide — amorphous |
FR |
231-545-4 |
7631-86-9 |
3 |
18 |
20 |
||||||||||||||||||||
|
Sodium hydrogensulphite |
DE |
231-548-0 |
7631-90-5 |
1 |
2 |
4 |
5 |
6 |
9 |
11 |
12 |
13 |
20 |
22 |
||||||||||||
|
Hydrogen chloride/Hydrochloric acid |
LV |
231-595-7 |
7647-01-0 |
2 |
||||||||||||||||||||||
|
Sodium chloride |
PT |
231-598-3 |
7647-14-5 |
5 |
||||||||||||||||||||||
|
Sodium bromide |
NL |
231-599-9 |
7647-15-6 |
2 |
4 |
6 |
7 |
9 |
11 |
12 |
13 |
|||||||||||||||
|
Orthophosphoric acid |
PT |
231-633-2 |
7664-38-2 |
4 |
||||||||||||||||||||||
|
Sodium hypochlorite |
IT |
231-668-3 |
7681-52-9 |
1 |
2 |
3 |
4 |
5 |
6 |
11 |
12 |
|||||||||||||||
|
Disodium disulphite |
DE |
231-673-0 |
7681-57-4 |
1 |
2 |
4 |
5 |
6 |
9 |
11 |
12 |
13 |
20 |
22 |
||||||||||||
|
Tetramethrin |
DE |
231-711-6 |
7696-12-0 |
18 |
||||||||||||||||||||||
|
Potassium permanganate |
SK |
231-760-3 |
7722-64-7 |
5 |
||||||||||||||||||||||
|
Hydrogen peroxide |
FI |
231-765-0 |
7722-84-1 |
1 |
2 |
3 |
4 |
5 |
6 |
11 |
12 |
|||||||||||||||
|
Nitrogen |
IE |
231-783-9 |
7727-37-9 |
18 |
||||||||||||||||||||||
|
7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole |
PL |
231-810-4 |
7747-35-5 |
6 |
11 |
12 |
13 |
|||||||||||||||||||
|
Sodium sulphite |
DE |
231-821-4 |
7757-83-7 |
1 |
2 |
4 |
5 |
6 |
9 |
11 |
12 |
13 |
20 |
22 |
||||||||||||
|
Sodium chlorite |
PT |
231-836-6 |
7758-19-2 |
2 |
3 |
4 |
5 |
11 |
12 |
20 |
||||||||||||||||
|
Copper sulphate |
FR |
231-847-6 |
7758-98-7 |
1 |
2 |
4 |
||||||||||||||||||||
|
Silver nitrate |
SE |
231-853-9 |
7761-88-8 |
1 |
||||||||||||||||||||||
|
Sodium chlorate |
PT |
231-887-4 |
7775-09-9 |
2 |
5 |
11 |
12 |
|||||||||||||||||||
|
Disodium peroxodisulphate/Sodium persulphate |
PT |
231-892-1 |
7775-27-1 |
4 |
||||||||||||||||||||||
|
Calcium hypochlorite |
IT |
231-908-7 |
7778-54-3 |
1 |
2 |
3 |
4 |
5 |
11 |
|||||||||||||||||
|
Chlorine |
IT |
231-959-5 |
7782-50-5 |
2 |
5 |
11 |
||||||||||||||||||||
|
Ammonium sulphate |
UK |
231-984-1 |
7783-20-2 |
11 |
12 |
|||||||||||||||||||||
|
Silver chloride |
SE |
232-033-3 |
7783-90-6 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
9 |
10 |
11 |
13 |
||||||||||||
|
Creosote |
SE |
232-287-5 |
8001-58-9 |
8 |
||||||||||||||||||||||
|
Pyrethrins and Pyrethroids |
ES |
232-319-8 |
8003-34-7 |
18 |
19 |
|||||||||||||||||||||
|
Garlic ext. |
PL |
232-371-1 |
8008-99-9 |
3 |
4 |
5 |
18 |
19 |
||||||||||||||||||
|
Lignin |
EL |
232-682-2 |
9005-53-2 |
1 |
2 |
3 |
4 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
||||||||||||
|
Boric acid |
NL |
233-139-2 |
10043-35-3 |
1 |
2 |
3 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
18 |
22 |
||||||||||
|
Chlorine dioxide |
PT |
233-162-8 |
10049-04-4 |
2 |
3 |
4 |
5 |
11 |
12 |
20 |
||||||||||||||||
|
Potassium sulphite |
DE |
233-321-1 |
10117-38-1 |
1 |
2 |
4 |
5 |
6 |
9 |
11 |
12 |
13 |
20 |
22 |
||||||||||||
|
Sodium hydrogen 2,2′methylenebis[4-chlorophenolate] |
LV |
233-457-1 |
10187-52-7 |
2 |
3 |
4 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
|||||||||||||
|
2,2-dibromo-2-cyanoacetamide |
DK |
233-539-7 |
10222-01-2 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
|||||||||||
|
Carbendazim |
DE |
234-232-0 |
10605-21-7 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
||||||||||||||||
|
Disodium octaborate tetrahydrate |
NL |
234-541-0 |
12280-03-4 |
1 |
2 |
3 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
||||||||||||
|
Trimagnesium diphosphide |
DE |
235-023-7 |
12057-74-8 |
18 |
20 |
23 |
||||||||||||||||||||
|
Copper(II) carbonate-copper(II) hydroxide (1:1) |
FR |
235-113-6 |
12069-69-1 |
8 |
||||||||||||||||||||||
|
Zineb |
IE |
235-180-1 |
12122-67-7 |
21 |
||||||||||||||||||||||
|
Ammonium bromide |
SE |
235-183-8 |
12124-97-9 |
2 |
4 |
6 |
7 |
9 |
11 |
12 |
||||||||||||||||
|
Hexaboron dizinc undecaoxide/Zinc borate |
ES |
235-804-2 |
12767-90-7 |
9 |
||||||||||||||||||||||
|
Pyrithione zinc |
SE |
236-671-3 |
13463-41-7 |
2 |
6 |
7 |
9 |
10 |
13 |
21 |
||||||||||||||||
|
Dodecylguanidine monohydrochloride |
ES |
237-030-0 |
13590-97-1 |
1 |
2 |
6 |
7 |
9 |
10 |
11 |
12 |
22 |
||||||||||||||
|
Potassium 2-biphenylate |
ES |
237-243-9 |
13707-65-8 |
6 |
9 |
10 |
13 |
|||||||||||||||||||
|
Bromine chloride |
NL |
237-601-4 |
13863-41-7 |
2 |
11 |
12 |
||||||||||||||||||||
|
(benzyloxy)methanol |
UK |
238-588-8 |
14548-60-8 |
2 |
6 |
9 |
10 |
11 |
13 |
|||||||||||||||||
|
Bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copper |
SE |
238-984-0 |
14915-37-8 |
9 |
21 |
|||||||||||||||||||||
|
Chlorotoluron |
ES |
239-592-2 |
15545-48-9 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
||||||||||||||||
|
Sodium p-chloro-m-cresolate |
FR |
239-825-8 |
15733-22-9 |
1 |
2 |
3 |
4 |
6 |
9 |
10 |
13 |
|||||||||||||||
|
Chloralose |
PT |
240-016-7 |
15879-93-3 |
14 |
15 |
23 |
||||||||||||||||||||
|
Dipotassium disulphite |
DE |
240-795-3 |
16731-55-8 |
1 |
2 |
4 |
5 |
6 |
9 |
11 |
12 |
13 |
20 |
22 |
||||||||||||
|
D-gluconic acid, compound with N,N″-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1) |
PT |
242-354-0 |
18472-51-0 |
1 |
2 |
3 |
4 |
6 |
||||||||||||||||||
|
Benzoxonium chloride |
CY |
243-008-1 |
19379-90-9 |
1 |
9 |
|||||||||||||||||||||
|
p-[(diiodomethyl)sulphonyl]toluene |
UK |
243-468-3 |
20018-09-1 |
6 |
7 |
9 |
10 |
12 |
13 |
|||||||||||||||||
|
Copper dihydroxide |
FR |
243-815-9 |
20427-59-2 |
8 |
||||||||||||||||||||||
|
Disilver oxide |
SE |
243-957-1 |
20667-12-3 |
11 |
||||||||||||||||||||||
|
Aluminium phosphide |
DE |
244-088-0 |
20859-73-8 |
14 |
18 |
20 |
23 |
|||||||||||||||||||
|
(benzothiazol-2-ylthio)methyl thiocyanate |
N |
244-445-0 |
21564-17-0 |
2 |
4 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
||||||||||||||
|
Bendiocarb |
UK |
245-216-8 |
22781-23-3 |
18 |
||||||||||||||||||||||
|
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Prallethrin |
EL |
245-387-9 |
23031-36-9 |
18 |
||||||||||||||||||||||
|
Potassium (E,E)-hexa-2,4-dienoate |
DE |
246-376-1 |
24634-61-5 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
|||||||||||||
|
.alpha.,.alpha.′,.alpha.″-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol |
AT |
246-764-0 |
25254-50-6 |
2 |
6 |
9 |
11 |
13 |
||||||||||||||||||
|
2-octyl-2H-isothiazol-3-one |
UK |
247-761-7 |
26530-20-1 |
4 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
|||||||||||||||
|
Cis-tricos-9-ene |
AT |
248-505-7 |
27519-02-4 |
18 |
19 |
|||||||||||||||||||||
|
Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride |
ES |
248-595-8 |
27668-52-6 |
2 |
7 |
9 |
10 |
|||||||||||||||||||
|
N′-tert-butyl-N-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine |
NL |
248-872-3 |
28159-98-0 |
7 |
9 |
10 |
21 |
|||||||||||||||||||
|
3-[3-(4′-bromo[1,1′-biphenyl]-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2-benzopyrone/Bromadiolone |
SE |
249-205-9 |
28772-56-7 |
14 |
||||||||||||||||||||||
|
(Z,E)-tetradeca-9,12-dienyl acetate |
AT |
250-753-6 |
30507-70-18 |
19 |
||||||||||||||||||||||
|
Decyldimethyloctylammonium chloride (2) |
251-035-5 |
32426-11-2 |
||||||||||||||||||||||||
|
Bromochloro-5,5-dimethylimidazolidine-2,4-dione |
NL |
251-171-5 |
32718-18-6 |
2 |
3 |
4 |
5 |
6 |
9 |
11 |
12 |
13 |
||||||||||||||
|
3-(4-isopropylphenyl)-1,1-dimethylurea/Isoproturon |
DE |
251-835-4 |
34123-59-6 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
||||||||||||||||
|
N-[[(4-chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide |
SE |
252-529-3 |
35367-38-5 |
18 |
||||||||||||||||||||||
|
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole/Imazalil |
DE |
252-615-0 |
35554-44-0 |
2 |
3 |
4 |
13 |
20 |
||||||||||||||||||
|
S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate/Azamethiphos |
UK |
252-626-0 |
35575-96-3 |
18 |
||||||||||||||||||||||
|
2-bromo-2-(bromomethyl)pentanedinitrile |
CZ |
252-681-0 |
35691-65-7 |
6 |
7 |
9 |
10 |
11 |
13 |
|||||||||||||||||
|
Benzyldimethyloleylammonium chloride (1) |
253-363-4 |
37139-99-4 |
||||||||||||||||||||||||
|
Calcium magnesium oxide/dolomitic lime |
UK |
253-425-0 |
37247-91-9 |
2 |
3 |
|||||||||||||||||||||
|
Calcium magnesium tetrahydroxide/calcium magnesium hydroxide/hydrated dolomitic lime |
UK |
254-454-1 |
39445-23-3 |
2 |
3 |
|||||||||||||||||||||
|
.alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate |
EL |
254-484-5 |
39515-40-7 |
18 |
||||||||||||||||||||||
|
Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride |
PL |
255-451-8 |
41591-87-1 |
9 |
||||||||||||||||||||||
|
Mixture of cis- and trans-p-menthane-3,8 diol/Citriodiol |
UK |
255-953-7 |
42822-86-6 |
1 |
2 |
19 |
||||||||||||||||||||
|
4,4-dimethyloxazolidine |
UK |
257-048-2 |
51200-87-4 |
6 |
11 |
12 |
13 |
|||||||||||||||||||
|
ethyl N-acetyl-N-butyl-.beta.-alaninate |
BE |
257-835-0 |
52304-36-6 |
19 |
||||||||||||||||||||||
|
.alpha.-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cypermethrin |
BE |
257-842-9 |
52315-07-8 |
8 |
9 |
18 |
||||||||||||||||||||
|
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Permethrin |
IE |
258-067-9 |
52645-53-1 |
2 |
3 |
5 |
8 |
9 |
18 |
22 |
||||||||||||||||
|
.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate/Deltamethrin |
SE |
258-256-6 |
52918-63-5 |
18 |
||||||||||||||||||||||
|
1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Empenthrin |
BE |
259-154-4 |
54406-48-3 |
18 |
||||||||||||||||||||||
|
3-iodo-2-propynyl butylcarbamate |
DK |
259-627-5 |
55406-53-6 |
6 |
7 |
8 |
9 |
10 |
11 |
13 |
||||||||||||||||
|
Tetrakis(hydroxymethyl)phosphonium sulphate(2:1) |
MT |
259-709-0 |
55566-30-8 |
2 |
6 |
9 |
11 |
12 |
||||||||||||||||||
|
3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin/Difenacoum |
FI |
259-978-4 |
56073-07-5 |
14 |
||||||||||||||||||||||
|
4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin/Brodifacoum |
IT |
259-980-5 |
56073-10-0 |
14 |
||||||||||||||||||||||
|
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole/Propiconazole |
FI |
262-104-4 |
60207-90-1 |
1 |
2 |
4 |
7 |
8 |
9 |
10 |
12 |
13 |
20 |
|||||||||||||
|
Quaternary ammonium compounds, coco alkyltrimethyl, chlorides (3) |
263-038-9 |
61789-18-2 |
||||||||||||||||||||||||
|
Quaternary ammonium compounds, benzylcoco alkyldimethyl, chlorides (1) |
263-080-8 |
61789-71-7 |
||||||||||||||||||||||||
|
Quaternary ammonium compounds, dicocoalkyl dimethyl, chlorides (2) |
263-087-6 |
61789-77-3 |
||||||||||||||||||||||||
|
Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides (2) |
263-090-2 |
61789-80-8 |
||||||||||||||||||||||||
|
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides (1) |
264-151-6 |
63449-41-2 |
||||||||||||||||||||||||
|
4,5-dichloro-2-octyl-2H-isothiazol-3-one |
N |
264-843-8 |
64359-81-5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
21 |
|||||||||||||||
|
2-chloro-N-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]benzamide |
IT |
264-980-3 |
64628-44-0 |
18 |
||||||||||||||||||||||
|
3,3′-methylenebis[5-methyloxazolidine]/Oxazolidin |
AT |
266-235-8 |
66204-44-2 |
2 |
6 |
10 |
11 |
12 |
13 |
|||||||||||||||||
|
N-cyclopropyl-1,3,5-triazine-2,4,6-triamine |
EL |
266-257-8 |
66215-27-8 |
18 |
||||||||||||||||||||||
|
Cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine/Fenpropimorph |
ES |
266-719-9 |
67564-91-4 |
6 |
7 |
8 |
9 |
10 |
12 |
13 |
||||||||||||||||
|
.alpha.-cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cyfluthrin |
DE |
269-855-7 |
68359-37-5 |
18 |
||||||||||||||||||||||
|
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides |
IT |
269-919-4 |
68391-01-5 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
17 |
22 |
|||||||||
|
Quaternary ammonium compounds, di-C6-12-alkyldimethyl, chlorides (2) |
269-925-7 |
68391-06-0 |
||||||||||||||||||||||||
|
Quaternary ammonium compounds, benzyl-C8-16-alkyldimethyl, chlorides (1) |
270-324-7 |
68424-84-0 |
||||||||||||||||||||||||
|
Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides |
IT |
270-325-2 |
68424-85-1 |
1 |
2 |
3 |
4 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
|||||||||||
|
Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides |
IT |
270-331-5 |
68424-95-3 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
22 |
||||||||||
|
Fatty acids, coco, reaction products with diethanolamine |
HU |
270-430-3 |
68440-04-0 |
3 |
||||||||||||||||||||||
|
Quaternary ammonium compounds, benzyl-C10-16-alkyldimethyl, chlorides (1) |
273-544-1 |
68989-00-4 |
||||||||||||||||||||||||
|
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1) |
MT |
273-545-7 |
68989-01-5 |
2 |
4 |
11 |
12 |
|||||||||||||||||||
|
Sodium N-(hydroxymethyl)glycinate |
AT |
274-357-8 |
70161-44-3 |
6 |
7 |
|||||||||||||||||||||
|
Amines, C10-16-alkyldimethyl, N-oxides |
PT |
274-687-2 |
70592-80-2 |
1 |
2 |
|||||||||||||||||||||
|
Pentapotassium bis(peroxymonosulphate) bis(sulphate) |
SI |
274-778-7 |
70693-62-8 |
1 |
2 |
3 |
4 |
5 |
11 |
12 |
||||||||||||||||
|
N,N′-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene)bis(octylammonium) dichloride |
HU |
274-861-8 |
70775-75-6 |
1 |
||||||||||||||||||||||
|
1,3-didecyl-2-methyl-1H-imidazolium chloride |
CZ |
274-948-0 |
70862-65-6 |
2 |
3 |
4 |
6 |
7 |
10 |
11 |
12 |
13 |
||||||||||||||
|
ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate/Fenoxycarb |
DE |
276-696-7 |
72490-01-8 |
8 |
||||||||||||||||||||||
|
Quaternary ammonium compounds, di-C8-18-alkyldimethyl, chlorides (2) |
277-453-8 |
73398-64-8 |
||||||||||||||||||||||||
|
1-[1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea/Diazolidinylurea |
LT |
278-928-2 |
78491-02-8 |
6 |
7 |
|||||||||||||||||||||
|
Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-) hexahydrate |
PL |
114915-85-4 |
2 |
3 |
4 |
|||||||||||||||||||||
|
Tributyltetradecylphosphonium chloride |
PL |
279-808-2 |
81741-28-8 |
2 |
4 |
9 |
11 |
12 |
||||||||||||||||||
|
Margosa ext. |
DE |
283-644-7 |
84696-25-3 |
18 |
19 |
|||||||||||||||||||||
|
Tar acids, polyalkylphenol fraction |
HU |
284-893-4 |
84989-05-9 |
2 |
3 |
|||||||||||||||||||||
|
Melaleuca alternifolia, ext./Australian Tea Tree Oil |
ES |
285-377-1 |
85085-48-9 |
1 |
2 |
3 |
||||||||||||||||||||
|
Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides |
IT |
287-089-1 |
85409-22-9 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
17 |
22 |
|||||||||
|
Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides |
IT |
287-090-7 |
85409-23-0 |
1 |
2 |
3 |
4 |
5 |
6 |
9 |
11 |
12 |
13 |
17 |
22 |
|||||||||||
|
Chrysanthemum cinerariaefolium, ext. |
ES |
289-699-3 |
89997-63-7 |
18 |
||||||||||||||||||||||
|
Urea, N,N′-bis(hydroxymethyl)-, reaction products with 2-(2-butoxyethoxy)ethanol, ethylene glycol and formaldehyde |
PL |
292-348-7 |
90604-54-9 |
2 |
6 |
11 |
12 |
13 |
||||||||||||||||||
|
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, bromides (1) |
293-522-5 |
91080-29-4 |
||||||||||||||||||||||||
|
Lavender, Lavandula hybrida, ext./Lavandin oil |
PT |
294-470-6 |
91722-69-9 |
19 |
||||||||||||||||||||||
|
Pine ext. |
LV |
304-455-9 |
94266-48-5 |
10 |
||||||||||||||||||||||
|
Quaternary ammonium compounds, [2-[[2-[(2-carboxyethyl)(2-hydroxyethyl)amino]ethyl]amino]-2-oxoethyl]coco alkyldimethyl, hydroxides, inner salts |
LT |
309-206-8 |
100085-64-1 |
1 |
2 |
3 |
4 |
6 |
7 |
10 |
11 |
12 |
13 |
|||||||||||||
|
Corn cob, powdered |
EL |
310-127-6 |
999999-99-4 |
14 |
||||||||||||||||||||||
|
1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea/Hexaflumuron |
PT |
401-400-1 |
86479-06-3 |
18 |
||||||||||||||||||||||
|
1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione |
NL |
401-570-7 |
89415-87-2 |
2 |
11 |
12 |
||||||||||||||||||||
|
1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol/Tebuconazole |
DK |
403-640-2 |
107534-96-3 |
7 |
8 |
9 |
10 |
|||||||||||||||||||
|
Reaction products of: glutamic acid and N-(C12-14-alkyl)propylenediamine |
DE |
403-950-8 |
164907-72-6 |
1 |
2 |
3 |
4 |
|||||||||||||||||||
|
Mixture of: (C8-18)alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate;(C8-18)alkylbis(2-hydroxyethyl)ammonium 2-ethylhexylhydrogenphosphate |
PL |
404-690-8 |
68132-19-4 |
6 |
7 |
9 |
||||||||||||||||||||
|
2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate/Transfluthrin |
NL |
405-060-5 |
118712-89-3 |
18 |
||||||||||||||||||||||
|
5,5-dimethyl-perhydro-pyrimidin-2-one .alpha.-(4-trifluoromethylstyryl)-.alpha.-(4-trifluoromethyl)cinnamylidenehydrazone/Hydramethylnon |
IE |
405-090-9 |
67485-29-4 |
18 |
||||||||||||||||||||||
|
3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether/Etofenprox |
AT |
407-980-2 |
80844-07-1 |
2 |
3 |
8 |
18 |
|||||||||||||||||||
|
6-(phthalimido)peroxyhexanoic acid |
IT |
410-850-8 |
128275-31-0 |
1 |
2 |
3 |
4 |
11 |
12 |
|||||||||||||||||
|
Methyl neodecanamide |
ES |
414-460-9 |
105726-67-8 |
19 |
||||||||||||||||||||||
|
Mixture of: alpha-cyano-3-phenoxybenzyl (Z)-(1R,3R)-[(S)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate;alpha-cyano-3-phenoxybenzyl (Z)-(1S,3S)-[(R)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate/Lambda cyhalothrin |
SE |
415-130-7 |
91465-08-6 |
18 |
||||||||||||||||||||||
|
1-(4-(2-cloro-a,a,a-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea/Flufenoxuron |
FR |
417-680-3 |
101463-69-8 |
8 |
18 |
|||||||||||||||||||||
|
2-butyl-benzo[d]isothiazol-3-one |
CZ |
420-590-7 |
4299-07-4 |
6 |
7 |
9 |
10 |
13 |
||||||||||||||||||
|
Tetrachlorodecaoxide complex |
DE |
420-970-2 |
92047-76-2 |
1 |
2 |
3 |
4 |
5 |
||||||||||||||||||
|
Mixture of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin/Flocoumafen |
NL |
421-960-0 |
90035-08-8 |
14 |
||||||||||||||||||||||
|
sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/Icaridine |
DK |
423-210-8 |
119515-38-7 |
19 |
||||||||||||||||||||||
|
Fipronil |
FR |
424-610-5 |
120068-37-3 |
18 |
||||||||||||||||||||||
|
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride |
PL |
426-020-3 |
51229-78-8 |
6 |
9 |
12 |
13 |
|||||||||||||||||||
|
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine/Imidacloprid |
DE |
428-040-8 |
138261-41-3 |
18 |
||||||||||||||||||||||
|
Thiamethoxam |
ES |
428-650-4 |
153719-23-4 |
8 |
9 |
18 |
||||||||||||||||||||
|
[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate/Imiprothrin |
UK |
428-790-6 |
72963-72-5 |
18 |
||||||||||||||||||||||
|
5-chloro-2-(4-chlorphenoxy)phenol |
AT |
429-290-0 |
3380-30-1 |
1 |
2 |
4 |
6 |
9 |
||||||||||||||||||
|
2-(1-methyl-2-(4-phenoxy-phenoxy)-ethoxy)-pyridine/Pyriproxyfen |
NL |
429-800-1 |
95737-68-1 |
18 |
||||||||||||||||||||||
|
3-benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine,4-oxide |
PT |
431-030-6 |
163269-30-5 |
4 |
6 |
7 |
9 |
10 |
13 |
|||||||||||||||||
|
Reaction products of diisopropanolamine with formaldehyde(1:4) |
HU |
432-440-8 |
220444-73-5 |
6 |
13 |
|||||||||||||||||||||
|
Reaction product of dimethyl adipate, dimethyl glutarate, dimethyl succinate with hydrogen peroxide/Perestane |
HU |
432-790-1 |
- |
1 |
2 |
3 |
4 |
5 |
11 |
12 |
||||||||||||||||
|
Bis(3-aminopropyl)octylamine |
CZ |
433-340-7 |
86423-37-2 |
2 |
3 |
4 |
11 |
12 |
13 |
|||||||||||||||||
|
(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine/Chlothianidin |
DE |
433-460-1 |
210880-92-5 |
3 |
8 |
18 |
||||||||||||||||||||
|
Peroxyoctanoic acid |
FR |
33734-57-5 |
2 |
3 |
4 |
11 |
12 |
|||||||||||||||||||
|
Cyclohexylhydroxydiazene 1-oxide, potassium salt |
AT |
66603-10-9 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
||||||||||||||||
|
Bis[1-cyclohexyl-1,2-di(hydroxy-.kappa.O)diazeniumato(2-)]-copper |
AT |
312600-89-8 |
2 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
||||||||||||||||
|
Silver zeolite A |
SE |
- |
2 |
4 |
5 |
7 |
9 |
|||||||||||||||||||
|
Bacillus sphaericus |
IT |
Micro-organism |
143447-72-7 |
2 |
18 |
|||||||||||||||||||||
|
Bacillus thuringiensis subsp. Israelensis Serotype H14 |
IT |
Micro-organism |
- |
2 |
5 |
18 |
||||||||||||||||||||
|
Bacillus subtilis |
DE |
Micro-organism |
- |
3 |
||||||||||||||||||||||
|
Alkyl-benzyl-dimethylammonium chloride/Benzalkonium chloride (1) |
Mixture |
8001-54-5 |
||||||||||||||||||||||||
|
Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6) |
FR |
Mixture |
55965-84-9 |
2 |
3 |
4 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
|||||||||||||
|
Amines, n-C10-16-alkyltrimethylenedi-, reaction products with chloroacetic acid |
IE |
Mixture |
139734-65-9 |
1 |
2 |
3 |
4 |
6 |
7 |
10 |
11 |
12 |
13 |
|||||||||||||
|
Quaternary ammonium iodides |
ES |
Mixture |
308074-50-2 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
||||||||||||||||
|
Mixture of 1-phenoxypropan-2-ol (EINECS 212-222-7) and 2-phenoxypropanol (EINECS 224-027-4) |
UK |
Mixture |
- |
1 |
2 |
3 |
4 |
6 |
10 |
11 |
13 |
|||||||||||||||
|
Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium hypochlorite produced in situ |
SK |
Mixture |
- |
2 |
3 |
4 |
5 |
|||||||||||||||||||
|
Potassium salts of fatty acids (C15-21) |
DE |
Mixture |
- |
2 |
||||||||||||||||||||||
|
Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22, saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or hydroxides)/BKC |
IT |
Mixture of EINECS listed substances |
- |
1 |
2 |
3 |
4 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
|||||||||||
|
Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/DDAC |
IT |
Mixture of EINECS listed substances |
- |
1 |
2 |
3 |
4 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
|||||||||||
|
Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/TMAC |
IT |
Mixture of EINECS listed substances |
- |
8 |
||||||||||||||||||||||
|
Sodium lignosulfonate |
HU |
Natural Polymer |
8061-51-6 |
12 |
||||||||||||||||||||||
|
Silver-zinc-aluminium-boronphosphate glass/Glass oxide, silver- and zinc-containing |
SE |
Not yet allocated |
398477-47-9 |
1 |
2 |
6 |
7 |
9 |
||||||||||||||||||
|
Silver sodium hydrogen zirconium phosphate |
SE |
Not yet allocated |
- |
1 |
2 |
3 |
4 |
7 |
9 |
10 |
||||||||||||||||
|
(±)-1-(.beta.-allyloxy-2,4-dichlorophenylethyl)imidazole/Technical grade imazalil |
DE |
Plant protection product |
73790-28-0 |
2 |
3 |
4 |
13 |
|||||||||||||||||||
|
Silicium dioxide/Kieselguhr |
FR |
Plant protection product |
61790-53-2 |
18 |
||||||||||||||||||||||
|
S-Methoprene/Isopropyl (s-(E,E))-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate |
IE |
Plant protection product |
65733-16-6 |
18 |
||||||||||||||||||||||
|
Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyrate |
PT |
Plant protection product |
66230-04-4 |
18 |
||||||||||||||||||||||
|
[1.alpha.(S*),3.alpha.]-(.alpha.)-cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2.2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/alpha-Cypermethrin |
BE |
Plant protection product |
67375-30-8 |
6 |
9 |
18 |
||||||||||||||||||||
|
Abamectin (Mixture of Avermectin B1a; > 80 %, EINECS 265-610-3; and Avermectin B1b; < 20 % EINECS 265-611-9) |
NL |
265-610-3 |
71751-41-2 |
18 |
||||||||||||||||||||||
|
Cyclopropanecarboxylic acid, 3-[(1Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethyl-, (2-methyl[1,1′-biphenyl]-3-ylmethyl ester, (1R,3R)-rel-/Bifenthrin/Biphenate |
FR |
Plant protection product |
82657-04-3 |
8 |
18 |
|||||||||||||||||||||
|
.alpha.-(4-Chlorophenyl)-.alpha.-(1-cyclopropylethyl)-1H-1,2,4-triazole-1-ethanol/Cyproconazole |
IE |
Plant protection product |
94361-06-5 |
8 |
||||||||||||||||||||||
|
3-(3-(4′-Bromo-(1,1′-biphenyl)-4-yl)-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxybenzothiopyran-2-one/3-((RS,3RS;1RS,3SR)-3-(4′-bromobiphenyl-4-yl-1,2,3,4-tetrahydro-1-napthyl)-4-hydroxy-1-benzothin-2-one/Difethialone |
N |
Plant protection product |
104653-34-1 |
14 |
||||||||||||||||||||||
|
Guazatine triacetate |
UK |
Plant protection product |
115044-19-4 |
2 |
||||||||||||||||||||||
|
4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile/Chlorfenapyr |
PT |
Plant protection product |
122453-73-0 |
6 |
7 |
8 |
9 |
10 |
12 |
13 |
18 |
|||||||||||||||
|
Aluminium sodium silicate-silver complex/Silver zeolite |
SE |
Plant protection product |
130328-18-6 |
6 |
7 |
13 |
||||||||||||||||||||
|
Aluminium sodium silicate-silver zinc complex/Silver-Zinc-Zeolite |
SE |
Plant protection Product |
130328-20-0 |
1 |
2 |
6 |
7 |
9 |
||||||||||||||||||
|
N-((6-Chloro-3-pyridinyl)methyl)-N′-cyano-N-methylethanimidamide/Acetamiprid |
BE |
Plant protection product |
160430-64-8 |
18 |
||||||||||||||||||||||
|
3-phenoxybenzyl (1R)-cis,trans-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-Phenothrin |
IE |
Plant protection product |
188023-86-1 |
18 |
||||||||||||||||||||||
|
Mixture of 5-Hydroxymethoxymethyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 59720-42-2, 16,0 %) and 5-Hydroxy-1-aza-3,7-dioxabicyclo(3.3.0)octane (EINECS 229-457-6, 28,8 %), and 5-Hydroxypoly[methyleneoxy]methyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 56709-13-8; 5,2 %) in water (50 %) |
PL |
Plant protection product |
- |
6 |
13 |
|||||||||||||||||||||
|
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers: 1R trans: 1RS only 1:1)/Bioallethrin/d-trans-Allethrin |
DE |
Plant protection product |
- |
18 |
||||||||||||||||||||||
|
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1)/d-Allethrin |
DE |
Plant protection product |
- |
18 |
||||||||||||||||||||||
|
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3)/Esbiothrin |
DE |
Plant protection product |
- |
18 |
||||||||||||||||||||||
|
Spinosad: fermentation product of soil micro-organisms containing Spinosyn A and Spinosyn D |
NL |
Plant protection product |
- |
3 |
18 |
|||||||||||||||||||||
|
Polyvinylpyrrolidone iodine |
SE |
Polymer |
25655-41-8 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
9 |
10 |
11 |
22 |
||||||||||||
|
Polymer of N-Methylmethanamine (EINECS 204-697-4 with (chloromethyl)oxirane (EINECS 203-439-8)/Polymeric quaternary ammonium chloride |
HU |
Polymer |
25988-97-0 |
2 |
11 |
12 |
||||||||||||||||||||
|
Polymer of formaldehyde and acrolein |
HU |
Polymer |
26781-23-7 |
3 |
||||||||||||||||||||||
|
Monohydro chloride of polymer of N,N′′′-1,6-hexanediylbis[N′-cyanoguanidine] (EINECS 240-032-4) and hexamethylenediamine (EINECS 204-679-6)/Polyhexamethylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium monohydrochloride) |
FR |
Polymer |
27083-27-8/32289-58-0 |
1 |
2 |
3 |
4 |
5 |
6 |
9 |
11 |
12 |
22 |
|||||||||||||
|
N,N,N′,N′–Tetramethylethylenediaminebis(2-chloroethyl)ether copolymer |
UK |
Polymer |
31075-24-8 |
2 |
9 |
11 |
12 |
13 |
||||||||||||||||||
|
Poly(hexamethylendiamine guanidinium chloride) |
FR |
Polymer |
57028-96-3 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
20 |
||||||||||
|
Poly(hexamethylenebiguanide) |
FR |
Polymer |
91403-50-8 |
1 |
2 |
3 |
4 |
9 |
10 |
11 |
||||||||||||||||
|
Poly(oxy-1,2-ethanediyl), .alpha.-[2-(didecylmethylammonio)ethyl]- .omega.-hydroxy-, propanoate (salt) |
IT |
Polymer |
94667-33-1 |
2 |
3 |
4 |
6 |
8 |
9 |
10 |
11 |
12 |
13 |
|||||||||||||
|
Copolymer of 2-propenal and propane-1,2-diol |
HU |
Polymer |
191546-07-3 |
6 |
7 |
10 |
13 |
|||||||||||||||||||
|
N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate |
EL |
Polymer |
214710-34-6 |
2 |
6 |
8 |
9 |
10 |
11 |
12 |
13 |
|||||||||||||||
|
Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) |
FR |
Polymer |
374572-91-5 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
9 |
10 |
11 |
12 |
13 |
20 |
||||||||||
|
(1) Covered by Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22, saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or hydroxides)/BKC. (2) Covered by Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/DDAC. (3) Covered by Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/TMAC. |
||||||||||||||||||||||||||
ANNEX III
Requirements for the complete dossier and the summary dossier
(a) The complete dossier must include the original test and study reports for each point of Annex IIA and IIB, or Annex IVA and IVB, to Directive 98/8/EC, and where specified the relevant parts of Annex IIIA and IIIB thereto, together with the summary dossier referred to in Article 11(1)(b) of that Directive.
(b) The summary dossier must include the following:
— in the case of a collective dossier, the name of all participants concerned and a person designated by them as being responsible for the collective dossier and the processing of the dossier in accordance with this Regulation,
— for each point of Annex IIA and IIB, or Annex IVA and IVB, to Directive 98/8/EC, and where specified the relevant parts of Annex IIIA and IIIB to the Directive, the summaries and results of studies and trials,
— list of references used,
— risk assessment,
— overall summary and assessment,
— a check by the participant or, where appropriate, by the person designated as responsible for a collective dossier of the completeness of the dossier.
(c) The formats made available by the Commission must be used for submission of the dossiers. In addition, the special software package (IUCLID) made available by the Commission must be used for those parts of the dossiers to which IUCLID applies. Formats and further guidance on data requirements and dossier preparation are available on the ECB homepage http://ecb.jrc.it/biocides
(d) For existing active substances that have been or are being evaluated under the review programme for plant protection products in accordance with Article 8(2) of Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market ( 8 ), the required format for an application for inclusion in Annex I thereto may be used for the preparation of the dossier for inclusion of the existing active substance in Annex I, IA or IB to Directive 98/8/EC, taking into account relevant differences in the dossier requirements. A summary of the dossier must be entered in IUCLID. Additional information related to the biocidal use must be submitted in accordance with the requirements of this Regulation.
( 1 ) OJ L 123, 24.4.1998, p. 1. Directive as last amended by Directive 2007/47/EC (OJ L 247, 21.9.2007, p. 21).
( 2 ) OJ L 228, 8.9.2000, p. 6. Regulation as amended by Regulation (EC) No 2032/2003 (OJ L 307, 24.11.2003, p. 1).
( 3 ) OJ L 307, 24.11.2003, p. 1. Regulation as last amended by Regulation (EC) No 1849/2006 (OJ L 355, 15.12.2006, p. 63).
( 4 ) OJ L 262, 27.9.1976, p. 201. Directive as last amended by Directive 2007/51/EC of the European Parliament and of the Council (OJ L 257, 3.10.2007, p. 13).
( 5 ) By Regulation (EC) No 1048/2005 (OJ L 178, 9.7.2005, p. 1); and Regulation (EC) No 1849/2006, (OJ L 355, 15.12.2006, p. 63).
( 6 ) OJ L 258, 26.9.2002, p. 15.
( 7 ) OJ L 167, 27.6.2012, p. 1.
( 8 ) OJ L 230, 19.8.1991, p. 1.